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Abstract 
Every day billions of cells in our bodies undergo apoptosis and are cleared through 
efferocytosis – a phagocytosis-like process in which phagocytes engulf and degrade 
apoptotic cells. Proper processing of efferosomes prevents inflammation and immunogenic 
presentation of antigens. In this thesis I determined that the early stages of efferosome 
maturation parallel that of the pro-immunogenic phagocytosis of pathogens. Mass 
spectrometry analysis of later maturation stages identified unique regulatory proteins on 
efferosomes and phagosomes. Keys among these were Rab17 and Rab45 on efferosomes 
versus Rab6b and PI-4-Kinase on phagosomes. The later would allow for antigen 
presentation from phagosomes, while the former would direct efferosome-derived antigens 
away from this presentation pathway. Moreover, positive regulators of MAP-kinase signaling 
were enriched on phagosomes, while negative regulators were enriched on efferosomes, 
perhaps indicating the mechanism through which efferocytosis inhibits inflammation. These 
regulators may account for the differences in inflammation and immunogenicity observed 
after efferocytosis versus phagocytosis.  
Keywords 
Macrophage, Efferocytosis, Efferosome, Apoptosis, Phagocytosis, Phagosome, Vesicular 
Trafficking, Antigen Presentation, Anti-inflammation, Cell Biology, Cell Signaling, Rab 
GTPases, Maturation, Eat-me Signal, Phosphatidylserine. 
 iii 
 
Acknowledgments 
I sincerely want to acknowledge my supervisor and mentor Dr. Bryan Heit for all his 
guidance, encouragement and support through my M.Sc studies. His broad scientific insight 
has inspired me to pursue the research in phagocytosis, especially efferocytosis. I greatly 
benefited from his constructive advice in scientific writing, presentation, time management, 
and expanding ideas in my research. His professionalism also inspired me to pursue research 
in the future. 
My research would not have been possible without great support from my advisory 
committee, Dr. Lakshman Gunaratnam and Dr. Jimmy Dikeakos. I would like to appreciate 
their great advice and discussion that led to develop this thesis. They guided me into the right 
direction, including helping me expand my scientific knowledge, providing constructive 
feedback on every work of mine. 
I am very grateful to everyone in the Heit lab, especially Dr. Ron Flannagan. He always 
provided me with an interpretation of data in different scientific ways and discussed for my 
research. His research also motivated me with his experiments over fields and insights of 
science. 
I really appreciate Dr. Fabiana Caetano who trained me for confocal microscopes at the 
Robarts confocal imaging facility. She always helped me not only during training sessions 
but also in the imaging of every experiment. 
Lastly I am very thankful to my parents, my brother, and my girlfriend for their limitless 
support and encouragement. I dedicate this thesis to them. 
 iv 
 
Table of Contents 
Abstract ............................................................................................................................... ii	  
Acknowledgments .............................................................................................................. iii	  
Table of Contents ............................................................................................................... iv	  
List of Tables ..................................................................................................................... vi	  
List of Figures ................................................................................................................... vii	  
Chapter 1 - Introduction ...................................................................................................... 1	  
1.1	   Apoptosis ................................................................................................................ 1	  
1.2	   Macrophage Subtypes ............................................................................................. 3	  
1.3	   Overview of Efferocytosis ...................................................................................... 4	  
1.4	   Phagocytosis as a Model of Efferocytosis ............................................................ 17	  
1.5	   Known Efferocytic Maturation Mechanisms ........................................................ 25	  
1.6	   Efferocytic Defects and Disease ........................................................................... 26	  
1.7	   Rationale ............................................................................................................... 27	  
1.8	   Hypothesis and Aims ............................................................................................ 28	  
Chapter 2 – Materials and Methods .................................................................................. 31	  
2.1	   Cell Line Culture and Human Macrophage Isolation ........................................... 31	  
2.2	   Primary Human Macrophage Differentiation ....................................................... 32	  
2.3	   Induction of Jurkat T Cell Apoptosis and PtdSer Flipping ................................... 32	  
2.4	   Induction of Neutrophil Apoptosis ....................................................................... 33	  
2.5	   Preparation of Synthetic Phagocytic and Efferocytic Targets .............................. 33	  
2.6	   Transfection .......................................................................................................... 34	  
2.7	   In Vitro Phagocytic and Efferocytic Assay ........................................................... 35	  
2.8	   Confocal and Fluorescent Microscopy ................................................................. 35	  
2.9	   Calculation of Phagocytic Index ........................................................................... 36	  
 v 
 
2.10	  Efferosome and Phagosome Isolation ................................................................... 36	  
2.11	  SDS-PAGE and Coomassie Staining .................................................................... 37	  
2.12	  Mass Spectrometry Analysis ................................................................................. 38	  
2.13	  Statistical Analysis ................................................................................................ 38	  
Chapter 3 – Results ........................................................................................................... 40	  
3.1	   Optimized In Vitro Efferocytosis Assay of Apoptotic Neutrophils ...................... 40	  
3.2	   Optimized In Vitro Efferocytosis Assay of Synthetic Apoptotic Targets ............. 48	  
3.3	   In Vitro Efferocytosis by Primary Human Macrophages ..................................... 51	  
3.4	   Efferosomes Acquire Rab5 and Rab7 Similarly to Phagosome Maturation ......... 55	  
3.5	   Efferosomes Undergo Fusion with Lysosomes .................................................... 67	  
3.6	   Identification of Regulator Proteins on Efferosomes ............................................ 67	  
Chapter 4 - Discussion ...................................................................................................... 78	  
4.1	   Rational of the Thesis: Efferosome Maturation Pathways and the Immune System
 78	  
4.2	   Hypothesis and Aims ............................................................................................ 80	  
4.3	   Development of an In Vitro Efferocytosis Model ................................................. 80	  
4.4	   Macrophage Subtypes and Efferocytosis .............................................................. 83	  
4.5	   Role of Rab5 and Rab7 in Efferosome Maturation .............................................. 84	  
4.6	   Novel Regulators Differentiate Efferosomal from Phagosomal Maturation ........ 87	  
4.7	   Summary and Future Aims ................................................................................... 92	  
References ......................................................................................................................... 94	  
Curriculum Vitae ............................................................................................................ 107	  
 vi 
 
List of Tables  
Table 1: Multiple efferocytic receptors are required to enhance efferocytosis ...................... 12	  
Table 2: Wash buffer used for efferosome and phagosome isolation ..................................... 39	  
Table 3: Lysis buffer used for efferosome and phagosome isolation ..................................... 39	  
Table 4: Summary of all proteins detected by mass spectrometry analysis of isolated 
efferosomes. ............................................................................................................................ 74	  
Table 5: Summary of all proteins detected by mass spectrometry analysis of isolated 
phagosomes. ............................................................................................................................ 76	  
 
 vii 
 
List of Figures 
Figure 1: Rab GTPases mediated phagosome maturation ...................................................... 19	  
Figure 2: Staurosporine (STS) induction of apoptosis in Jurkat T cells. ................................ 41	  
Figure 3: Generation of apoptotic neutrophils by heat-shock. ................................................ 44	  
Figure 4: J774.2 cells efferocytose apoptotic neutrophils. ..................................................... 46	  
Figure 5: J774.2 cells efferocytose apoptotic cell-mimicking beads. ..................................... 49	  
Figure 6: Efferocytosis by primary human macrophages ....................................................... 53	  
Figure 7: Tracking Rab5 and Rab7 on phagosomes ............................................................... 57	  
Figure 8: Tracking Rab5 and Rab7 on efferosomes ............................................................... 59	  
Figure 9: Rab5 recruitment to apoptotic-neutrophil containing efferosomes. ........................ 61	  
Figure 10: Rab7 recruitment to apoptotic-neutrophil containing efferosomes. ...................... 63	  
Figure 11: Quantification of Rab5 and Rab7 on phagosomes and efferosomes. .................... 65	  
Figure 12: M0 macrophages fuse lysosomes to efferosomes. ................................................ 68	  
Figure 13: Multiple unique proteins were recovered from efferosomes and phagosomes. .... 71	  
 
  
1 
 
 
 
Chapter 1 - Introduction 
1.1 Apoptosis 
Apoptosis, the programmed cell death of old, damaged or unneeded cells, is triggered by 
multiple factors including exogenous stimuli such as pathogen infection and engagement 
of pro-apoptotic receptors, and endogenous stimuli such as aging, and damage from 
physical or chemical stresses1. Apoptotic cells must be cleared in order to maintain an 
organism’s normal physiological functions and tissue homeostasis. Upon recognition by 
phagocytic cells, apoptotic cells are cleared promptly and efficiently. For example, 
neutrophils in the peripheral circulation system have a high incidence of apoptosis due to 
their short half-life, but the number of apoptotic neutrophils remains at a low basal level 
due to their efferocytic removal by macrophages in the bone marrow2. In instances where 
apoptotic cells are not efficiently removed, chronic inflammation and autoimmunity can 
occur. Apoptotic cells display many distinct hallmarks that are excluded from healthy 
cells such as membrane blebs on their surfaces as a result of increased intracellular 
hydrostatic pressure from actomyosin contractility of the cortical cytoskeleton3. This 
blebbing process is induced as a part of the apoptotic signaling pathway, which is driven 
by cysteine-dependent aspartate-driven proteases termed caspases4. Upon initiation of 
apoptosis by internal stress and damage (intrinsic pathway), pro-apoptotic factors induce 
the release of cytochrome C from mitochondria, which then complexes with the cytosolic 
protein apoptosis activating factor-1 (Apaf-1). Caspase 9 is recruited to this complex, 
forming a structure termed the “apoptosome”, which then activates caspase 3, an 
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executioner caspase that begins the disassembly of the cell5. Blebbing of the apoptotic 
cell is initiated by activated caspase 3, which cleaves the C-terminus of Rho-associated 
coiled-coil-containing protein kinase 1 (ROCK1), forming a constitutively active enzyme 
which then phosphorylates myosin light chain kinase. The resultant activation of myosin 
II leads to cortical actin contraction and increased intracellular hydrostatic pressure, thus 
producing membrane blebs. Actin is cleared from the growing blebs, and later replaced in 
mature blebs through late stage actin repolymerization3. Caspase 3 also activates other 
cell degrading proteins such as Caspase-activated DNAse (CAD) which fragments the 
nuclear DNA, which is then dispersed to the forming blebs6.  Other cellular 
compartments (e.g. the Golgi apparatus, endoplasmic reticulum, and mitochondria) are 
broken down and packaged in a similar fashion as nuclear DNA fragments, while 
activation of enzymes such as lipid scramblases and phospholipases lead to the exposure 
of “find-me” and “eat-me” signals which enable the recognition of apoptotic cells by 
phagocytes (discussed in Section 1.3). Once released, these blebs are termed apoptotic 
bodies, which are ultimately identified and removed through efferocytosis7.  
Throughout this process the apoptotic cell membrane remains intact, thus preventing the 
release of intracellular proteins, while the small size of the released blebs plus the 
exposure of “find-me” and “eat-me signals” enhances uptake byphagocytes3, 8. However, 
if apoptotic cells are not cleared, the membrane integrity of apoptotic bodies becomes 
unstable, culminating with the release of intracellular materials into the extracellular 
milieu through a process called secondary necrosis. This can lead to negative 
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immunological consequences including chronic inflammation and autoimmune diseases1, 
9, 10, 11. 
1.2 Macrophage Subtypes 
Macrophages, a type of professional phagocyte, have classically been regarded as 
leukocytes whose main function is the phagocytosis (engulfment and clearance) of 
pathogens. They also have minor roles in antigen presentation and regulation of the 
innate and adaptive immune systems through cytokine production. Recent studies 
revealed that macrophages have additional important roles in homeostasis and wound 
healing, in addition to their roles during infection. This multi-functional activity of 
macrophages is mediated in part by their polarization into distinct subsets, each with 
unique functions: 1) M1 macrophages which engage in the pro-inflammatory/pro-
phagocytic activities classically assigned to macrophages, 2) M2 macrophages which 
drive wound healing and tissue remodeling responses, and 3) M0 (unpolarized) 
macrophages which patrol tissues and may engage in homeostatic processes such as 
efferocytosis within uninfected/undamaged tissues12, 13.  
In vitro, each subtype can be derived from monocytes isolated from peripheral blood, 
which are then differentiated by the addition of either granulocyte-macrophage colony 
stimulating factor (GM-CSF) or macrophage colony stimulating factor (M-CSF), 
followed by administration of additional cytokines14. GM-CSF plus the addition of pro-
inflammatory compounds such as IFN-γ and LPS result in the differentiation of M1 
macrophages, whereas M-CSF plus regulatory cytokines such as IL-4 or IL-13 generate 
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M2 macrophages.  M0 macrophages are produced by culturing with M-CSF alone, thus 
avoiding the polarizing effects of inflammatory or regulatory cytokines12.  
Jaguin et al. characterized in the patterns of cytokine production in each macrophage 
type12. M1 macrophages, which both produce and react to pro-inflammatory cytokines 
such as IFN-γ and TNF-α, exhibit enhanced phagocytosis of pathogens compared to other 
macrophage subtypes. M2 cells function through the production of anti-inflammatory 
cytokines such as TGF-β and enhance following internalization of apoptotic cells or entry 
into wound sites15. Unpolarized M0 macrophages appear to resemble resident 
macrophages in healthy tissues, and display a phenotype distinct from M1 cells, but with 
some similarities to M2 cells16. Importantly, M0 cells can differentiate into either M1 or 
M2 cells, although it is not clear if M1 or M2 cells are capable of further differentiation14, 
17. Functional differences between M1 and M2 macrophages have been widely studied, 
especially in their production of reactive oxygen species production after phagocytosis; 
M1 cells produce high NADPH oxidase activity following phagocytosis, whereas M2-
like macrophages produce minimal NADPH oxidase activity18. This may result in 
differences in antigen presentation and degradation of phagocytic/efferocytic cargos19. 
Some of these functional differences are explored later in this thesis. 
1.3 Overview of Efferocytosis 
Efferocytosis, the process through which phagocytes recognize and ingest (phagocytose) 
apoptotic cells, maintains tissue homeostasis by regulating cell numbers and remodels 
tissues in an anti-inflammatory fashion. The clearance of apoptotic cells is achieved 
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through the stepwise removal of apoptotic corpses by: 1) Recruitment of phagocytes to 
“find-me” signals secreted by apoptotic cells, 2) Display of “eat-me” signals on apoptotic 
cells which are then bound by efferocytic receptors on phagocytes, 3) Internalization of 
apoptotic cells by receptor mediated signaling pathways, and 4) Digestion of apoptotic 
cells by an efferosome maturation process within the phagocyte11. Although efferocytosis 
is considered as an anti-inflammatory process, the mechanism by which apoptotic cells 
are degraded in a fashion which prevents inflammation and maintains immunological 
silence is not understood. 
Phagocytes migrate to sites of apoptosis by following “find-me” signals, soluble 
chemotactic molecules released from apoptotic cells such as lysophosphatidylcholine 
(LPC)20. Receptors on phagocytes then bind to “eat-me” signals displayed by apoptotic 
corpses. Among the many “eat-me” signals, phosphatidylserine (PtdSer) is a well-
characterized and widely utilized apoptotic signal21. Apoptotic cells also express 
additional “eat-me” signals such as calreticulin and oxidized lipids on their surfaces21, 22. 
These are recognized by multiple surface receptors on phagocytes, which bind to 
apoptotic cells either directly or indirectly through soluble bridging molecules termed 
opsonins. Upon internalization, apoptotic corpses are retained in a membrane-sealed 
vacuolar structure called the efferosome, where it is processed and degraded23. The 
resulting self-antigens are either presented without activating co-stimulatory molecules or 
presentation is avoided completely after the efferosome maturation process is complete11, 
24. These processes which comprise efferocytosis are explored in greater detail below.  
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Find-me signals 
Prior to recognition and internalization of apoptotic cells, phagocytes must be recruited to 
the location in which cells are undergoing apoptosis. This occurs through the release of 
“find-me” signals which act as chemoattractants that direct phagocytes to sites of 
apoptosis. The range of these “find-me” signals depends on their concentration and half-
life, which may vary between tissues21. “Find-me” signals identified to-date include LPC, 
fractalkine (CXCL3), adenosine triphosphate (ATP) and uracil triphosphate (UTP) 
nucleotides, and sphingosine-1-phosphate (S1P)21.  
Peter et al. showed that calcium-independent phospholipase-A2, activated by caspase 3, 
produces LPC which is then released into the extracellular matrix20. This soluble LPC 
signals through the receptor G2A, G-protein-coupled receptor found on macrophages, 
thus allowing macrophages to migrate towards the apoptotic cell. However, these 
observations are controversial as the study of Lauber et al. demonstrated that 
significantly higher concentrations of LPC were required for chemotaxis than were 
normally released by apoptotic cells25. In fact, this study showed that the membrane 
damage caused by production of the quantity of LPC required for chemotaxis would lead 
to lysis of the apoptotic cell. The role of LPC as a find-me signal is controversial for an 
additional two reasons; namely that it is relatively insoluble and therefore is not expected 
to diffuse and form gradients in vivo, and because it is unclear if G2A is truly a receptor 
for LPC26.  
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Fractalkine is a membrane tethered cytokine with dual functions as an adhesion molecule 
and chemokine27. Apoptotic neurons and B cells rapidly produce and shed fractalkine, 
which then attracts macrophages and microglia via the fractalkine receptor CX3CR27. 
Miksa et al. showed that fractalkine also contributed to recognition and engulfment of 
apoptotic cells by upregulating milk fat globule EGF factor 8 (MFG-E8) expression, an 
opsonin which enhances efferocytosis via the MerTK efferocytic receptor27. However, 
fractalkine’s role in attracting phagocytes to sites of apoptosis remains elusive. Although 
fractalkine enhanced MFG-E8 production in microglia, efferocytosis by microglia was 
not observed27. Moreover, the role of fractalkine in attracting macrophages at sites where 
it is produced – e.g. Kupffer cells in the liver and alveolar macrophages in the lungs - has 
not been studied, meaning further research is required to elucidate fractalkine’s role as a 
“find-me” signal. Finally, fractalkine’s role as a find-me signal appears to be limited to 
immune cells undergoing apoptosis, rather than a universal find-me signal produced by 
all apoptotic cells. 
Apoptotic cells release small amounts of ATP and UTP that induce chemotaxis of 
phagocytes to apoptotic cells26. Again, the role of these nucleoside triphosphate remains 
controversial as ATP and UTP can also function as danger-associated molecular patterns 
(DAMPs) which are usually associated with necrosis and initiation of pro-inflammatory 
responses11. Once ATP and UTP are present in the extracellular space, phagocytes 
respond via the purinergic receptor P2Y2. Again, the role of these “find-me” signals 
remains unclear, as these nucleotides are short-lived in the extracellular milieu as they are 
rapidly degraded by extracellular nucleotidases26, 28. Thus ATP and UTP’s function as 
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find-me signals would be limited to attracting neighbouring phagocytes rather than cells 
residing in the circulation or at more distal sites.  
The best characterized “find-me” signal is sphingosine-1-phosphate (S1P). Unlike the 
previously mentioned find-me signals, S1P appears to be produced by all apoptotic cells, 
is highly soluble, and has a sufficiently long half-life to recruit cells over long distances29. 
S1P is derived from sphingomyelin, a lipid found in the plasma membrane. Once cells 
undergo apoptosis, sphingomyelinase processes sphingomyelin to sphingosine, followed 
by caspase activated sphingosine kinases phosphorylating sphingosine to form soluble 
sphingosine-1-phosphate (S1P). S1P induces chemotaxis of phagocytes through the S1P 
receptor, with chemotaxis occurring at physiologically relevant concentrations of S1P 11, 
29, 30. Moreover, S1P is anti-inflammatory31, as would be expected of a “find-me” signal 
released during apoptosis. 
How these various “find-me” signals interact to optimize in recruiting phagocytes is not 
completely elucidated. For example it is not yet clear whether they are synergistic or non-
synergistic in attracting phagocytes, and how they interact with proposed inhibitory 
“don’t find-me” signals32. 
Eat-me signals 
Once professional phagocytes are recruited to a site where cells are undergoing apoptosis, 
phagocytes must distinguish healthy cells from apoptotic cells prior to engulfment. 
Apoptotic cells are recognized by several “eat-me” signals present on the extrafacial 
surface of their plasma membrane. The plasma membrane of apoptotic cells displays 
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numerous changes in glycosylation patterns of proteins and lipids, changes in lipid 
composition and changes in surface charge, all while maintaining an intact membrane11. 
These changes to the plasma membrane all act as “eat-me” signals which are recognized 
by receptors on phagocytes11, 26. Of these “eat-me” signals, phosphatidylserine (PtdSer), 
is the best characterized. PtdSer is normally restricted to the inner leaflet of the plasma 
membrane, but is flipped to the outer leaflet plasma membrane during apoptosis. This 
PtdSer flipping to the outer leaflet is dependent of caspase activity during apoptosis, in 
which the transmembrane protein 16F (TMEM16F) acts as a scramblase that randomly 
sorts phospholipids, including PtdSer and phosphotidylethanolamine (PtdEtn), in a 
calcium-dependent manner across the leaflets of the plasma membrane33. The signalling 
that induces this process is still poorly understood, but it is established that the formation 
of a cytosolic Ca2+ gradient is required to activate TMEM16F33. The same study showed 
that knockout of Tmem16f, using small hairpin RNA, downregulates the scrambling of 
PtdSer and PtdEtn during apoptosis. In addition, Scott syndrome patients have defective 
TMEM16F due to a splice mutation of TMEM16F and their platelets and blood cells 
cannot expose PtdSer and PtdEtn on the outer leaflet of the plasma membrane 33.  
Additional “eat-me” signals include calreticulin, intracellular adhesion molecule 3 
(ICAM3), and binding of serum proteins such thrombospondin and complement C1q to 
the cell surface11. Calreticulin is a protein normally located in the endoplasmic reticulum 
(ER), sarcoplasmic reticulum (SR) and nucleus. However, once cells undergo apoptosis, 
calreticulin is transported via the secretory pathway to the plasma membrane where it 
becomes accessible to its receptor, low density lipoprotein receptor-related protein
10 
 
 
 
 (LRP)/CD91, which is expressed on macrophages35. Apoptotic cells also expose other 
molecules such as oxidized lipids and unusually glycosylated lipids and proteins, which 
are engaged by scavenger receptors such as CD3622. Despite the large number of 
identified “eat-me” signals, only PtdSer has been studied in detail, and is the most 
commonly used apoptotic cell surface marker due to its exposure on apoptotic cells in 
abundant quantities, as well as the identification of several well characterized PtdSer 
receptors on phagocytes11. It is unlikely that PtdSer on its own is sufficient for 
efferocytosis, as some healthy cells also display PtdSer on the outer leaflet of their 
plasma membrane without being targeted by phagocytes. For example, platelets expose 
PtdSer as part of the clotting process, while maturing B and T cells expose PtdSer in 
lymph nodes for an unknown purpose10, 36, 37, 38. A part of the reason these cells may not 
be removed is the co-expression of CD31 and an integrin associated protein, CD47, 
which act as “don’t eat-me” signals. The function of CD31 is not well understood, but 
CD47 is known to bind to a specific receptor, signaling regulatory protein α (SIRPα), 
which contains an immunoreceptor tyrosine-based inhibition motif (ITIM) that inhibits 
phagocytosis. Thus CD31 and CD47 on healthy cells appear to prevent efferocytosis 
through inhibiting phagocytic signaling10, 11, 35.  
Efferocytic receptors mediate internalization of apoptotic cells  
Once professional phagocytes recognize “eat-me” signals the phagocytes quickly 
internalize the apoptotic cell. This is driven by two main groups of efferocytic receptors– 
those that directly bind to “eat-me” signals (e.g. TIM-4, Stabilin2, CD36 and BAI1) and 
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those which indirectly bind to “eat-me” signals (e.g. Tyro-3-Axl-MER and αvβ5) via 
opsonins (e.g. Gas6, MFG-E8)10, 11.  
TIM-4 (Table 1) has recently been highlighted as an important apoptotic cell receptor, 
and is able to support the binding and internalization of apoptotic cells independent of 
opsonins. A recent study showed that internalization of PtdSer-coated glass beads that 
mimic apoptotic cells was dependent on TIM-4, with TIM-4 knockout mouse bone 
marrow derived macrophages (BMDM) being unable to internalize these beads. However, 
this paper likely over-simplified what is occurring, as other studies have shown that 
PtdSer on its own does not act as an “eat-me” signal, with additional signals such as the 
oxidation of the PtdSer being required for efferocytosis to occur22, 39, 40. Internalization of 
PtdSer-coated beads required crosslinking of TIM-4 and the β1 integrin, which led to 
downstream activation of Src family and focal adhesion kinases (FAK), followed by actin 
polymerization driven by activation of Rac1 and Rac234. Additional PtdSer receptors may 
also be involved in this internalization process. For example, brain-specific angiogenesis 
inhibitor 1(BAI1, Table 1), a G-protein coupled receptor, binds to PtdSer and cardiopilin 
via a binding site composed of five thrombospondin type 1 repeats (TSRs). Upon binding 
of PtdSer on apoptotic cells, BAI1 induces activation of the Rac1 guanine exchange 
factor (GEF) complex ELMO/DOCK180 to mediate Rac-activation, leading to 
internalization of the apoptotic cell. BAI1 knockout in primary astrocytes and J774 
macrophages decreased internalization of apoptotic thymocytes and carboxylate beads 
that mimic apoptotic cells, supporting the concept that efficient efferocytosis requires the 
concordant activation of several receptors30, 41.  
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Table 1: Multiple efferocytic receptors are required to enhance efferocytosis 
Professional phagocytes express multiple efferocytic receptors that optimize capture and 
engulfment of apoptotic cells. Receptors either bind directly to PtdSer or indirectly via 
opsonins that connect receptors with “eat-me” signals and enhance internalization of 
apoptotic cells.  
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Receptors	   Opsonins	   Eat-­‐me	  signals	   References	  
TIM4	   −	   PtdSer	   34	  
BAI1	   −	   PtdSer	   41	  
CD36	   −	   oxLipids	  (ex.	  oxPtdSer)	   42	  
Stabilin-­‐2	   −	   PtdSer	   43	  
CD91	   Calreticulin,	  C1q,	  MBL	   Modified	  
Glycoproteins/Glycolipids	  
44	  
MER	   GAS6,	  Protein	  S,	  Tubby	  
and	  tubby-­‐like	  protein	  1	  
PtdSer	   10,	  11,	  45,	  46	  
αvβ3/5	   MFG-­‐E8	   PtdSer	   10,	  11	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CD36 (Table 1) is a class B scavenger receptor that binds to various ligands including 
oxidized LDL (oxLDL) and oxidized lipids. In atherosclerosis this receptor drives the 
accumulation of cholesterol inside macrophages, forming foam cells22. In addition to 
removing oxLDL, CD36 also acts as an efferocytic receptor by binding to oxidized lipids 
including oxidized PtdSer22. Early studies revealed that the PtdSer binding site in CD36 
is separate from the LDL binding site22, 42. Critically, a recent study shows CD36 to be 
capable of engulfing apoptotic cells in primary mouse peritoneal macrophages (MPM), 
with binding occurring between CD36 and oxidized PtdSer rather than normal PtdSer22. 
Interestingly, CD36 knockout primary MPM show decreased internalization of oxidized 
PtdSer-coated vesicles versus increased non-oxidized PtdSer-coated vesicles, hinting that 
CD36 may act to both drive efferocytosis and inhibit the removal of cells displaying 
PtdSer in a non-apoptotic (e.g. non-oxidized) context22.  
Stabilin-2 (Table 1) contributes to internalization of apoptotic cells through binding 
PtdSer via extracellular epidermal growth factor like domain repeats (EGFrps). Stabilin-2 
induces downstream signaling through the intracellular adaptor protein GULP, but the 
resulting signaling process remains elusive. Importantly, the integrin binding domain 
(FAS1) of Stabilin-2 directly interacts with integrin αvβ5 and activates 
ELMO/DOCK180/Rac complex to induce actin polymerization followed by 
internalization of apoptotic cells43. This may allow this receptor to engage the classical 
integrin-mediated phagocytosis internalization pathway10. 
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Previous studies by Gardai et al. introduced CD91 (known as a scavenger receptor and 
LDL-receptor-related protein, Table 1) on macrophages, which binds to calreticulin on 
apoptotic cells35. Apoptotic cells translocate calreticulin, an ER chaperone, to the plasma 
membrane. Engagement of calreticulin by CD91 initiates efferocytosis6. In addition to 
binding calreticulin, CD91 mediates efferocytosis in response to a number of other “eat-
me” signals, including C1q deposited on the apoptotic cell surface, the binding of 
mannose binding lectin (MBL) to glycoproteins and glycolipids modified by apoptotic 
processes44. 
PtdSer and other “eat-me” signals on apoptotic cells are also bound by opsonins such as 
protein S, Gas6, and MFG-E8 (Table 1). These opsonins act to bridge these “eat-me” 
signals efferocytic receptors such as the Tyro-3-Axl-MER (TAM, Table 1) family of 
receptors and integrins such as αvβ3 and αvβ510, 11, 43. The signaling of these receptors has 
not been elucidated, but they are known to play a central role in homeostasis in the eye45, 
46 and in preventing autoimmune disorders such as lupus47. While not thoroughly 
understood, it is likely that these opsonin-dependent receptors cooperate with the 
receptors that directly bind to “eat-me” signals, culminating in fast and efficient 
internalization of apoptotic cells. 
Common signaling pathways driving apoptotic cell internalization 
The signaling of most efferocytic receptors remains unknown, although recent studies 
have provided some insights into functions of a small number of these receptors. 
Interestingly, many of these studies have shown that integrin-mediated signaling is a key 
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component of several efferocytic receptors34, 45 despite apoptotic cell binding is largely 
dependent on non-integrin receptors. Outside of efferocytosis, integrins play major roles 
in a wide range of biological activities including chemotaxis, adhesion, and phagocytosis. 
All integrins are heterodimers composed of α and β subunits. Each subunit has a large 
ligand-binding extracellular domain, a single membrane spanning domain and a short 
lumenal domain which mediates integrin cell signaling via various tyrosine kinases and 
adaptor proteins48. As described above, several apoptotic receptors interact with integrins 
as co-receptors, and appear to utilize the integrin signaling pathway to mediate apoptotic 
cell internalization. Integrins associated with efferocytosis include αvβ3 and αvβ5, with 
siRNA-knockout of both integrins in macrophages decreasing efferocytosis by more than 
60%34.  Addition of antagonistic RGD peptides or anti-αvβ3 antibody also reduced 
phagocytosis of apoptotic neutrophils by primary human macrophages to a similar 
degree49. It is unclear at this time if the integrins normally associated with phagocytosis 
(e.g. αMβ2) are involved in efferocytosis. 
Upon integrin activation, FAK is activated by auto-phosphorylation and recruits Src 
kinases via its Src-homology 2 (SH2) domain. Subsequent tyrosine phosphorylation on 
FAK by Src kinases recruits CRK2-associated substrate (CAS) and phosphatidylinositol 
3-kinases (PI3-K) to FAK10, 48, 49. Lastly CRK2 and dedicator of cytokine 180 (DOCK180) 
are recruited to the FAK complex. Vav, a Ras GEF, is recruited to DOCK180-ELMO1 
complex to activate Rac1. Active Rac1 and CDC42 together activate Arp2/3 which then 
induces actin polymerization and cytoskeleton rearrangement. Ultimately, the resulting 
actin remodeling induces formation of membrane protrusions which envelope and 
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internalize the apoptotic cell10, 11, 34, 50. Once enveloped, Vav activates RhoA, which in 
turn activates ROCK followed by activation of myosin light chain kinase. This drives 
actin contraction through phosphorylation of the myosin light chain. The resulting actin 
contraction pulls the enveloped apoptotic cell into the phagocyte, resulting in formation 
of an efferosome. Because RhoA impairs actin polymerization it can negatively regulate 
apoptotic cell internalization if active during the initial stages of envelopment. However, 
when activated near the end of the envelopment stage, RhoA’s induction of actin 
contraction is key for full internalization of the apoptotic cell and its subsequent 
degradation11. 
1.4 Phagocytosis as a Model of Efferocytosis 
The signaling molecules and vesicular fusion events that mediate the degradation of a 
phagocytosed apoptotic cell remain unexplored in the mammalian system. However, 
previous studies in the nematode Caenorhabditis elegans suggests that the same 
degradative pathway is responsible for degrading both efferosomes and phagosomes51, 52. 
Phagocytosis is the process through which professional phagocytes internalize and 
destroy pathogens, and is crucial to both innate and adaptive immunity52. Professional 
phagocytes (e.g. macrophages and neutrophils) recognize and internalize and destroy 
large particles, greater than 0.5 µm53. In addition to removing and degrading pathogens, 
phagocytosis leads to the display of phagosome-derived antigens to peripheral lymphoid 
cells and expression of pro-inflammatory cytokines. As such phagocytosis is pro-
inflammatory and immunogenic, the opposite of efferocytosis. Despite the opposite 
immunological outcomes, efferocytosis and phagocytosis appear to share some 
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similarities in the cellular processes they use for degradation, and thus we used 
phagocytosis as a guide for our investigations into efferocytosis. 
Phagocytosis is a receptor-mediated process that can be driven by more than 20 different 
pathogen binding receptors which allow refined immune reactions to different types of 
pathogens10, 52. Indeed, some phagocytic receptors act as pattern-recognition receptors 
(PRRs) which detect pathogen-associated molecular patterns (PAMPs) on bacteria, fungi 
and parasites. For example, the phagocytic receptor dectin-1 binds β-glucans on fungal 
pathogens10. Not all phagocytic receptors act as PRRs; some (e.g. FcγRI) instead bind to 
pathogens via opsonins such as immunoglobulins (e.g. IgG), which in turn bind to surface 
antigens on pathogens10. Once the pathogen engages the phagocytic receptors on 
macrophages, the plasma membrane of the phagocyte is extended and envelops the 
receptor-engaged pathogen, eventually drawing the pathogen into an intracellular 
vacuolar structure that matures into a bactericidal compartment via fusion with 
endosomes and lysosomes54. This is orchestrated by changes in membrane 
phosphatidylinositol (PtdIns)-derived phospholipids and recruitment of regulatory 
proteins that drive the step-wise maturation of nascent phagosomes into phagolysosomes. 
First, early endosomes are recruited to the nascent phagosome by the Rab5 GTPase, 
where they fuse with the nascent phagosome to form an early phagosome (Figure 1). 
Rab5 is then replaced by Rab7, which mediates fusion between the phagosome and late 
endosomes and lysosomes, forming a phagolysosome. A key component driving this 
process at the early phagosome stage is Vps34, a class III phosphatidylinositol 3-kinase  
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Figure 1: Rab GTPases mediated phagosome maturation 
Once pathogens ( > 0.5 µm) are engulfed by macrophages, newly formed membrane-
sealed phagosomes undergo step-wise maturation process mediated by Rab 5 and 7 
GTPases, with subsequent changes in membrane phospholipids and lumenal pH. Each 
maturation stage is associated with acidification from endosomal and lysosomal fusion, 
wherein pathogens are degraded. Figure adapted from Dr. Heit. 
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(PI3K). Vps34 phosphorylates phosphatidylinositol (PI) to form phosphatidylinositol-3-
phsophate (PI(3)P), which mediates further recruitment of early endosomes and their 
fusion to early phagosomes10. PIKFYVE, a PI5-Kinase is recruited to, and then 
phosphorylates PI(3)P to form PI(3,5)P252. This triggers the exchange of Rab5 for Rab7, 
thus enabling fusion of the phagosome with late endosomes and lysosomes, and thus 
driving transition of the phagosome first to a late phagosome and then to a 
phagolysosome55. It is during this later stage of phagosome maturation where the bulk of 
phagosome acidification occurs, thus activating the degradative enzymes delivered 
through lysosomal fusion. The combined effect of acidification and degradative enzyme 
activation kills the pathogens within the phagosome10, 51, 52. 
The roles of Rab GTPases in endosome trafficking and phagosome maturation  
The Rab GTPases (Ras-related protein in brain) is a group of small GTPases, composed 
of over 60 members, that localize specifically to intracellular membranes56. Rab GTPases 
cycle between active and inactive states when bound to GTP or GDP respectively10, 56. 
Rab GTPase activation is mediated by guanine nucleotide exchange factors (GEFs) that 
replace GDP for GTP, thus activating the Rab. Rab GTPases are crucial in delivery and 
fusion of cellular component-containing vesicles between organelles. These GTPases 
control traffic of these vesicular cargoes via several components: 1) SNARE complexes 
control the specific membrane fusion, 2) Motor proteins (e.g. dynein/dynactin) transport 
vesicles along the microtubular network, and 3) Cytosolic coat molecules that recruit 
specific molecular components to vesicles. Inactivation of Rab proteins is mediated by 
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GTPase-activating proteins (GAPs) that induce the hydrolysis of GTP to form GDP. An 
additional protein, Rab GDP dissociation inhibitor (GDI), maintains the inactive form of 
the GTPases, designates the delivery site of inactive Rab GTPases, and recycles 
inactivated Rab to the cytosol10, 56, 57, 58.  
Rab5 and 7 directly contribute to phagosomal maturation (Figure 1). The nascent 
phagosome undergoes fusion with early endosomes where it acquires Rab5. Active Rab5 
recruits Vps34 the class III PI3K that synthesizes PI(3)P, in turn recruiting additional 
Rab5 effector proteins such as early endosome antigen 1 (EEA1)10. In yeast, Rab5 
contributes to the Rab5 to Rab7 transition by recruiting a Rab7 GEF, composed of Mon1 
and Ccz1, but their functions in mammalian system are not well-elucidated59. Rab7 
replaces Rab5 in the transition state from early phagosomes to late phagosomes. In the 
end, Rab7-interacting lysosomal proteins (RILP) and the long splice-variant of oxysterol-
binding protein related-protein1 (ORP1L) are recruited by Rab7 to late phagosomes 
where they act as Rab7 effectors. These Rab7 effectors induced linkages between 
microtubule proteins and phagosomes, driving the movement of the phagosome to the 
perinuclear area where they undergo fusion with lysosomes and late endosomes, thus 
forming phagolysosomes52. Lysosome-associated membrane proteins 1 and 2 (LAMP-1 
and -2) are also significant late phagosomal membrane proteins, which are critical for 
Rab7 recruitment and preservation of lysosomal membrane integrity52. A recent study of 
Rab34 has shown that Rab34 also localizes to phagosomes where it is involved in the 
size-dependent delivery of cargo from late endosomes and lysosomes. Specifically, 
Rab34, accompanied by its effector Munc 13-2, aids in the delivery of large (>70kDa) 
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lysosomal contents to the maturing phagosome in Rab7 independent manner60. In 
summary Rab GTPases are crucial in regulating the membrane traffic and vesicular 
fusion that drives phagosome maturation, and enable the step-wise maturation of the 
phagosome through sequential fusion with early endosomes, late endosomes and finally 
lysosomes. 
Phagosome acidification and recruitment of degradative enzymes 
As phagosomes undergo maturation they reduce their passive proton permeability10. At 
the same time Rab5 and Rab7 mediated vesicular fusions deliver vacuolar ATPases (V-
ATPases) to maturing phagosomes. This V-ATPase pumps protons from the cytosol into 
the phagosome, leading the phagosome to acidify as it matures into a phagolysosome. 
The phagosomes begins with the same pH as the intracellular milieu (~7.4), drops to a pH 
of 6.5 in the early phagosome stage, and reaches a pH of 4.5 by the phagolysosome 
stage10, 61. This thousand-fold increase in proton concentration cannot be achieved 
passively, and instead requires active pumping by the V-ATPase.  
The resulting acidity activates many pH-dependent degradative enzymes such as 
cathepsins, lipases, and other lysosomal acid hydrolases, which degrade the pathogen10, 19. 
This pH drop is also important for antigen presentation on MHC II molecules, as 
activation and loading of MHC II is driven by an acid-dependent protease that cuts the 
invariant chains that retains MHC II in an unloaded conformation. A recent study has 
shown that polarized macrophages such as M1 and M2 cells undergo different NADPH 
oxidase production18. In addition, a study of dendritic cells and M0-like bone marrow 
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derived murine macrophages showed different superoxide production by NADPH 
oxidase alter the phagosomal pH through consumption of phagosomal protons to form 
H2O262, 63. Thus it is predictable that phagosomes of M1 macrophages acidify slower and 
to a lesser extent than M0 or M2 macrophages due to their higher NADPH oxidase 
activity. Importantly, pro-inflammatory cytokines such as IFN-γ and PAMPs such as LPS 
not only stimulate the polarization of macrophages into M1 cells but also induce NADPH 
oxidase expression, suppressing the rate of acidification in the phagosomes of M1 cells. 
In contrast, M2-like macrophages, with similar low NADPH oxidase activity as M0-like 
macrophages, express fewer components and lower levels of the NADPH oxidase 
complex that may allow for faster acidification and a lower terminal pH18, 62. Expected 
prompt acidification in M2 cells may also leads to rapid cargo degradation which appears 
to degrade proteins before antigens can be loaded onto MHC II, preventing activation of 
the adaptive immune system. In contrast, the slow acidification of M1 phagosomes leads 
to stronger antigen presentation. While this presentation is important following the 
phagocytosis of a pathogen, the increased NADPH oxidase activity in M1 cells may 
produce oxidized self-antigens derived from apoptotic cells cargo’s, potentially leading to 
autoimmune antigen presentation18, 19. In summary, phagosome acidification contributes 
to many phagosomal functions, including not only activation of the phagosomal 
degradative pathways, but also in regulating antigen presentation and perhaps in the 
formation of autoantigens. 
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1.5 Known Efferocytic Maturation Mechanisms 
While the efferocytic maturation process is not as well understood as the phagocytic 
process, some of the mechanisms have been studied in the C. elegans nematode model51. 
This study explored efferosome maturation in C. elegans and determined that it proceeds 
through a pathway similar to that of phagocytosis. In C. elegans, many cells undergo 
apoptosis during the nematode developmental processes. Evolutionarily, C. elegans and 
mammalian system share a common receptor-mediated signaling pathway that activates 
CED-10/Rac, leading to a phagocytosis-like internalization processes in which membrane 
ruffles and protrusions engulf apoptotic cells. Common phagosome maturation markers 
such as Rab5 and Rab7 GTPases were found to be recruited to C. elegans efferosomes in 
the same order and with similar time as with phagosomes51. The apoptotic cell containing 
efferosomes recruited Rab5 and Rab5 effectors such as VPS-34. Rab7 was recruited at 
later time points, replacing Rab5 on the efferosomal membrane without co-localization51. 
Unlike mammalian phagocytosis, in C. elegans Rab5 was required for internalization, 
with the Rab5 knockout causing an accumulation of non-internalized apoptotic cells. In 
contrast, Rab7 knockout allowed for maturation to progress to the Rab5 step, but 
eventually the buildup of non-degraded apoptotic cells inhibited further uptake, leading to 
a block in apoptotic cells internalizaiton51.  
In contrast, our preliminary results using RAW264.7 murine macrophages showed a 
prolonged accumulation of Rab5 on efferosomes that contained apoptotic thymocytes and 
red blood cells (data not shown, by Dr. Bryan Heit), a finding also observed by other 
groups in dendritic cells64, 65. In our experiments, PI(3)P was retained on efferosomes, 
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further indicating a lack of Rab5 to Rab7 transition. This suggested that the efferosome 
maturation process in mammalian cells was different from that used by C. elegans. 
Because of these distinct differences in efferosome maturation we became very interested 
in how the efferocytosis maturation pathway differed from phagocytosis, especially in 
how this altered processing impacts antigen presentation and inflammation in the 
mammalian system. 
1.6 Efferocytic Defects and Disease 
The importance of efferocytosis in maintaining homeostasis is emphasized in diseases 
where efferocytosis is defective. Generally apoptotic cells maintain membrane integrity 
and are efficiently efferocytosed by professional phagocytes without releasing any 
intracellular components. For example, the majority of developing thymocytes in the 
thymus become apoptotic, and yet it is nearly impossible to detect uncleared apoptotic 
thymocytes due to the high rate of efferocytosis by resident macrophages66. Deficiencies 
in efferocytic receptors such as CD93 lead to the accumulation of apoptotic cells in the 
thymus67, which would then be expected to lose membrane integrity and release their 
intracellular components through a process termed secondary necrosis. Some of the 
released cellular components can engage TLR and other pro-inflammatory receptors68. 
These components, termed alarmins, include proteins such as the nuclear protein high-
mobility group box1 (HMGB1) as well as metabolites such as ATP3. In addition, 
secondary necrosis releases self-proteins which may be endocytosed by phagocytes, and 
due to the pro-inflammatory nature created by the simultaneous release of alarmins, may 
be presented as autoantigens along with immunostimulatory cytokines and co-stimulatory 
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molecules. Indeed, this release of self-antigens and alarmins from uncleared thymocytes 
in CD93 knockout mice causes an autoimmune diseases similar to systemic lupus 
erythematous (SLE)3. Mutations in a number of efferocytic receptors are associated with 
the onset of SLE and other autoimmune diseases, highlighting the importance of 
efferocytosis in maintaining immune homeostasis67, 69. 
In addition to autoimmunity, failures in efferocytosis can lead to the development of 
chronic inflammation such as atherosclerosis. During atherosclerosis macrophages in the 
arterial wall become apoptotic in response to the uptake of large quantities of cholesterol. 
Normally, these apoptotic macrophages are efferocytosed by neighbouring macrophages. 
However, for unknown reasons in some people this homeostatic process fails, leading to 
the accumulation of uncleared apoptotic macrophages in the vascular intima70. In some 
patients these defects are induced by inherited mutations in efferocytic receptors and their 
opsonins (e.g. MerTK, MFG-E8)71, 72. These uncleared apoptotic macrophages become 
necrotic, accumulating over time to form an atherosclerotic plaque. This structure is weak 
and prone to rupture - the resulting thrombus can dislodge, potentially evoking an acute 
myocardial infarct or ischemic stroke66. Clearly, successful apoptotic cell clearance is 
beneficial not only to homeostasis, but also in preventing clinically important 
autoimmune and inflammatory diseases. 
1.7 Rationale 
The preliminary results from our lab, as well as the work with dendritic cells by 
Ackerman et al.64 and Jancic et al.65 suggest that efferocytosis proceeds through a 
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maturation process unique from that utilized by phagocytosis. This study aims to 
elucidate the maturation process of efferocytosis in mammalian cells, with a focus on the 
role played by the vesicular trafficking system during efferosome maturation and 
identifying of potential unique protein regulators found on efferosomes. I believe that a 
unique maturation process is required to maintain homeostasis through preventing the 
efferosome from maturing into the same pro-inflammatory and immunogenic 
compartment as the phagosome. Indeed, evidence suggest that defects in efferocytosis 
cause or promote several chronic inflammation and autoimmune diseases, suggesting that 
the normal efferocytic process is inherently non-inflammatory66. In this study we will use 
murine and primary human macrophages to elucidate the molecular pathway regulating 
the maturation process of efferosomes and to identify unique protein regulators found on 
efferosomes versus phagosomes.  
 
1.8 Hypothesis and Aims 
Because efferocytosis and phagocytosis have different inflammatory and immunogenic 
outcomes, I hypothesized that phagocytic and efferocytic maturation pathways are 
regulated by fusions with different intracellular compartments, and that these fusion 
events are regulated by novel mediators recruited either to phagosomes or to efferosomes. 
To investigate my hypothesis, I proposed the following research aims: 
Research Aim 1. Establish an in vitro macrophage model of efferocytosis.  
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Rationale: Macrophages engulf apoptotic cells in a receptor-dependent manner, but these 
receptors are differentially expressed on different macrophage subtypes. To ensure 
consistent and reproducible results, I: 1) Identified macrophage cell lines and 
differentiated primary human macrophages subtypes with high efferocytic capacity, and 
2) Developed reproducible cell-based and bead-based efferocytic targets that were 
employed in later aims. 
Research Aim 2: To characterize the acquisition of common maturation markers 
(i.e. Rab5, Rab7, LAMP-1) on efferosomes. 
Rationale: The Rab GTPases Rab5 and Rab7 are critical regulators that direct 
remodeling phagosomes and endosomes. However, the role of these Rab proteins in 
efferocytosis is poorly understood in mammalian cells. By assessing the recruitment of 
Rab5 and Rab7, as well as the recruitment of other markers of key vesicular 
compartments, we can address the role of these proteins in efferosome maturation. One 
key marker is LAMP-173, a well-known marker found in late endosomes and lysosomes. 
Lysosomal fusion to phagosomes can be confirmed via immunostaining of LAMP-1 or 
by following maturation in cells transfected with fluorescent LAMP-1. Together, tracking 
these markers will characterize the role of these regulators on efferosome maturation. 
To address this aim, I: 1) Tracked the recruitment of Rab5 and Rab7 on efferosomes. 2) 
Tracked LAMP-1 recruitment to efferosomes to determine if lysosomal fusion was 
occurring. 
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Research Aim 3: To identify proteins that influence efferosome maturation through 
an unbiased mass spectrometry based approach. 
Rationale: Since we expect efferosome maturation to occur through a novel maturation 
pathway, it is insufficient to merely test known regulators, and as such an unbiased 
approach is needed to identify any novel regulatory factors. To identify these unique 
proteins, mass spectrometry analysis of isolated efferosomes and phagosomes was 
performed. To accomplish this aim I: 1) Recovered efferosomes using phospholipid-
coated silica-magnetic beads as apoptotic cell mimics, and 2) Identified several novel 
maturation regulators on the purified efferosomes and phagosomes using mass 
spectrometry. 
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Chapter 2 – Materials and Methods 
2.1 Cell Line Culture and Human Macrophage Isolation 
Human Jurkat T cells (gift from Dr. Lina Dagnino, Department of Physiology and 
Pharmacology, Western University) and murine macrophage cell line J774.2 (ATCC) 
were cultured at 37 °C in 5% CO2 in RPMI 1640 with 10% fetal bovine serum (FBS) (all 
from Wisnet). RAW264.7 cells were cultured in DMEM + 10% FBS. Cultures were split 
when they reached 80% of confluence. For phagocytosis and efferocytosis assay, 5 x 105 
J774.2 or RAW264.7 cells were cultured on sterile coverslips.  
Human primary monocytes were isolated from blood donated by healthy donors between 
the ages of 18 and 65. Blood was collected in the lab under approval from Western 
university’s Health Science Research Ethic Board using methods meeting the guidelines 
of the Tri-Council Policy Statement on human research. Blood was layered over an equal 
volume of lympholyte poly (Cedarlane), and centrifuged at 500 x g for 35 minutes at 
22 °C. The top cell layer of peripheral blood mononuclear cell (PBMC) was collected and 
washed with PBS. Monocytes were separated from PBMC by adhesion to glass or plastic 
surface - PBMC’s were resuspended in RPMI 1640 (300 µl /well). For phagocytic assays, 
300 µl of suspension was added to a sterile 18mm diameter coverslips placed into a well 
of a 12-well tissue culture plate and incubated at 37 °C in 5% CO2 for 1 hour. Non-
adherent (non-monocyte) PBMC’s were removed by a wash with 37 °C PBS. 1ml of 
RPMI 1640 with cytokines (see below) was added to each well. For mass spectrometry a 
total of 3.6 ml PBMC suspension was added to a 1-well gelatin-covered plate. An hour 
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later non-adherent cells were removed by washing as above and 12ml of RPMI 1640 with 
cytokines (see below) was added to each plate. 
2.2 Primary Human Macrophage Differentiation 
Adherent monocytes were differentiated over 7 days into each subtype of macrophages 
through the addition of specific cytokines. M0 macrophages were differentiated by the 
addition of M-CSF (10 ng/µl) alone for 7 days.  M1 macrophages were differentiated in 
GM-CSF (20 ng/µl) for 5 days followed by the addition of IFN-γ (10 ng/ml) and LPS 
(250 ng/ml). M2 macrophages were cultured in M-CSF (10 ng/μl) followed by the 
addition of IL-4 (10µg/ml) on day 5. All cells completed differentiation on day 7 and 
remained viable until day 1074.  
2.3 Induction of Jurkat T Cell Apoptosis and PtdSer Flipping 
Apoptosis was induced in Jurkat T cells by treating 2.5 mM staurosporine (STS) in RPMI 
1640 and incubated at 37 °C in 5% CO2 for 2.5 hours. Jurkat T cells were then washed 
three times with PBS at room temperature and then resuspended to 1ml of PBS. Annexin 
V (1/1000, eBioscience) was added to Jurkat T cells in 1 ml of imaging buffer (25 mM 
HEPES, 0.8% NaCl, 5.4 mM KCl, 1.3 mM CaCl22H2O, and 1mM MgCl2 in 100ml 
ddH2O with pH 7.4) and incubated for 5 minutes, followed by three washes in PBS with 
2.5 mM CaCl2 at room temperature and then resuspended in 1 ml of imaging buffer. To 
flip PtdSer independently of apoptosis, Jurkat T cells (no STS) were treated with 10 µM 
ionomycin (Fisher Scientific) and stained with annexin V as above. Untreated Jurkat T 
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cells were stained with annexin V (1/1000) in 1 ml of imaging buffer as above. Images of 
all Jurkat cells were acquired using the protocol described in section 2.8. 
2.4 Induction of Neutrophil Apoptosis 
The polymorphonuclear neutrophil layer (lower band of cells produced during the density 
gradient centrifugation in method 2.1) was collected and washed with PBS at 4 °C. PBS 
was aspirated gently and the neutrophils quickly and gently resuspended in 12ml ice cold 
water for 20 seconds to lyse remaining red blood cells. Lysis was stopped after 20 
seconds by the addition of 4 ml of 0.6 M KCl solution. Neutrophils were washed with 
PBS a second time and resuspended in 2 ml of RPMI 1640 + 10% heat-inactivated 
autologous serum. Apoptosis was induced by heat-shocking the cells at 43 °C for 45 min, 
followed by an incubation at 37 °C in 5% CO2 for 3 hours for recovery75. Necrosis was 
induced by heating the neutrophils at 55°C for 1 hour. After washing with PBS twice, 
apoptotic/necrotic neutrophils were suspended in RPMI 1640 and labeled with eFlour670 
cell proliferation dye (5 mM, eBioscience) to identify them in efferocytosis assays. 
Apoptosis and necrosis were detected by co-staining of annexin V and propidium iodide 
in imaging buffer at 37°C for 5 min. 
2.5 Preparation of Synthetic Phagocytic and Efferocytic 
Targets 
Silica and magnetic beads were coated with lipids and IgG in order to prepare beads that 
function as apoptotic mimics and phagocytic targets respectively76. Lipid-coated beads 
were prepared using silica beads (3.14 µm, Bangs Laboratories) or silica-coated magnetic 
beads (5µm, Bioclone) in order to non-covalently attach a bilayer of phosphatidylserine 
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(PtdSer: 19.8%), phosphatidylcholine (PtdCho: 80%) and biotinylated 
phosphatidylethanolamine (Biotin-PtdEtn: 0.2%, all lipids from Avanti Polar Lipids). 
Control beads were prepared using the same mixture minus the PtdSer. The mixture of 
silica beads and lipids were dried under nitrogen gas for 1 hour. Lipid coated beads were 
then suspended with 20 mM Tris-HCl pH 7.4 and washed multiple times with PBS. For 
mass spectrometry, magnetic beads were coated only with PtdSer (20%) and PtdCho 
(80%) to prepare apoptotic targets. IgG coated beads were prepared by mixing the same 
silica or silica-coated magnetic beads as above with purified human IgG antibodies 
(Sigma). 20 µl of human IgG were coated onto 300 µl of silica/silica-coated magnetic 
beads in PBS. The mixture was incubated for 1 hour at room temperature, washed once 
with PBS, and kept at 4 °C until use.  
2.6 Transfection 
J774.2 and RAW264.7 cells were cultured at 5×105 per coverslips and incubated at 37°C 
with 5% CO2 overnight. 3µg of plasmid DNA (mouse pmGFP, mouse Rab5-eGFP, 
mouse Rab7-pmCherry, mouse Rab7-eGFP) was mixed with 100 µl of serum-free RPMI 
1640 and 9 µl of FuGene-HD (Promega) transfection reagent added. This mixture was 
incubated for 15 min at room temperature according to the manufacturer’s manual. The 
mixture was added drop-wise to a single well of cells in a 12-well plate, and the cells 
were incubated overnight before use.  
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2.7 In Vitro Phagocytic and Efferocytic Assay 
J774.2, RAW264.7, and ANA-1 cells were cultured on coverslips in 12-well plates and 
transfected with pmGFP, Rab5-eGFP, Rab7-pmCherry or Rab7-eGFP. Primary 
macrophages were cultured on coverslips in 12-well plates without transfection. 
Apoptotic neutrophils and PtdSer-coated silica beads were prepared as described in 2.4 
and 2.5 and utilized as apoptotic targets. IgG-coated silica beads were prepared as 
described in 2.3 and utilized as phagocytic targets. 1×106 of neutrophils, PtdSer-coated 
silica beads, PtdCho-silica beads or IgG-coated silica beads in 200 µl of RPMI were 
added to each well of macrophages, centrifuged at 1500 rpm for 1 minute, at 4°C, and 
then incubated at 37°C for 10 to 30 minutes. Each well was then washed with PBS three 
times and fixed with 4% PFA. Wells with PtdSer-silica beads and PtdCho-silica beads 
were labeled with fluorescent-conjugated streptavidin (1/1000). Wells with neutrophils 
were blocked in blocking buffer (0.5% skim milk in PBS) for 30 minutes and then, 
stained with mouse anti-human CD18 antibody (1/500, Developmental Studies 
Hybridoma Bank) and goat-anti-mouse secondary fluorescent conjugated antibody (1/500, 
Jackson Laboratories) for 30 minutes. Wells with IgG-coated silica beads were stained 
with a fluorescent-conjugated anti-mouse Fab secondary antibody (1/500, Jackson 
Laboratories). 
2.8 Confocal and Fluorescent Microscopy 
Confocal images were captured using a Leica TCS SP5 II scanning confocal microscope 
(Robarts Research Institute) equipped with HeNe1/2 and Argon/2 lasers and a 
60X/1.20NA objective. Widefield fluorescent images were captured using an Olympus 
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IX-70 microscope equipped with a 60X/0.9NA phase contrast objective running 
μManager software77. 
2.9 Calculation of Phagocytic Index 
Lipid-coated or IgG coated beads were added to wells containing cultured macrophages, 
1 x 106 beads per well in a 12-well plate, and then centrifuged at 1500 RPM for 1 minute 
at 4°C and then incubated at 37°C for 30 minutes. After washing with PBS twice, non-
internalized beads were stained with streptavidin (1/1000) or goat-anti-mouse Fab-Cy5 
(1/500) at 37°C for 5 minutes. Macrophages were washed with PBS twice, and then fixed 
with 4% paraformaldehyde (PFA) for 30 minutes. Phase-contrast and fluorescence 
images of the efferocytic assays were captured as per method 2.8. Images were analyzed 
with Image J (NCBI) to count internalized beads per each macrophage in the field of 
view. A minimum 40 macrophages were analyzed per experiment. Phagocytic index of 
macrophages was calculated by dividing the total number of internalized beads by total 
number of macrophages. 
2.10 Efferosome and Phagosome Isolation 
M0 macrophages were cultured on gelatin-covered tissue culture plates for 7 days as 
described in 2.1 and 2.2. PtdSer-magnetic beads and IgG-magnetic beads in 3ml of RPMI 
were added to each plate of M0 macrophages. M0 macrophages efferocytosed (PtdSer-
magnetic beads) and phagocytosed (IgG-magnetic beads) for 40 min at 37 °C, then 
treated with ReCLIP reagent (Reverse Cross-Link Immuno-Precipitation, 1:1 mix of 
Dithio-bismaleimidoethane and Dithiobis[succinimidyl propionate) for 30 minutes at 
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room temperature78. ReCLIP solution was then aspirated and 10 ml of a quenching 
solution (20mM of Tris-Cl pH 7.4 and 5mM of L-Cysteine) was added and incubated at 
room temperature for 10 min. Macrophages were then washed with PBS, placed on the 
ice and scrapped into 10ml of lysis buffer (Table 3). Suspended macrophages were then 
lysed using a nitrogen bomb, 10 minutes at 300 psi, on ice. A magnetic column was used 
to recover magnetic beads-containing efferosomes and phagosomes. Efferosomes and 
phagosomes were washed three times with 1ml of wash buffer (Table 2) and recovered 
using a magnetic column. Efferosomes and phagosomes were solubilized in 30 µl 1X 
Laemmli buffer (from 4X Laemmli buffer with 2.4 ml of 1 M Tris pH 6.8, 0.8 g of SDS 
stock, 4 ml of 100% Glycerol, 0.01% of Brombophenol blue, and 2.8 ml of ddH2O) with 
protease/phosphatase inhibitors (Fisher Scientific) and 50 mM DTT (Fisher Scientific), 
incubated at 37°C for 30 min to reverse the ReCLIP crosslinking, and then boiled for 5 
min to denature the proteins for SDS-PAGE.  
2.11 SDS-PAGE and Coomassie Staining 
Phagosome and efferosome isolates from 2.10 were separated using 4-20% Mini-
PROTEIN gel (Bio-Rad) for approximately 2 hours at 100 V. Gels were fixed (40% 
ethanol and 10% of glacial acetyl acid) followed by a quick wash with clean water, then 
stained with coomassie blue (Bio-Rad) for 20 hours. Gels were then destained in clean 
water for 3 hours. Destained protein gels were imaged on a protein gel tray of the GelDoc 
EZ imager (Bio-Rad) to visualize recovered proteins. Gels were stored in clean water 
prior to mass spectrometry. 
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2.12 Mass Spectrometry Analysis 
Protein bands on coomassie gels were picked into 96-well plates by an Ettan Robotic 
Spot-picker machine located in the functional proteomics facility (Department of 
Biochemistry, Western University). Gel slices were destained with 50 mM ammonium 
bicarbonate and 50% acetonitrile, treated with 10 mM DTT and 55 mM iodoacetamide, 
and then digested with trypsin. Peptides were extracted by a solution of 1% formic acid 
and 2% acetonitrile and freeze dried. Dried peptide samples were then resuspended in a 
solution of 10% acetonitrile and 0.1% trifluoroacetic acid. Mass spectrometry analysis of 
each sample was performed using an AB Sciex 5800 TOF/TOF System, MALDI 
TOF/TOF (Framingham, MA, USA) by Kristina Jurcic (MALDI facility manager). Raw 
mass spectrometry data analysis was performed using MASCOT database search 
(http://www.matrixscience.com). Proteins were then divided into groups based on their 
protein scores.  
2.13 Statistical Analysis 
GraphPad prism software was used for all tests. Unless otherwise noted a one-tailed 
unpaired student t-test was used for analysis. Data are presented as mean ± standard error 
of the mean. p values ≤ 0.05 are considered to be significant and are indicated by *. 
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Table 2: Wash buffer used for efferosome and phagosome isolation 
Ingredient Concentration (mM) 
Sucrose 250 
HEPES 10 
MgCl 3 
NaVO4 1 
 
Table 3: Lysis buffer used for efferosome and phagosome isolation 
Ingredient Amount 
Wash buffer (Table 1) 1 ml 
Protease/phosphatase inhibitors 1:100 dilution* 
DNAse I 1: 50 dilution* 
PMSF 0.25 mM 
Okadaic acid 200 nM 
NaF 10 mM 
* Dilution of commercially provided stock 
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Chapter 3 – Results 
3.1 Optimized In Vitro Efferocytosis Assay of Apoptotic 
Neutrophils 
To ensure reproducible efferocytosis, I needed to establish efficient and reproducible 
methods to generate apoptotic targets. Initially I selected immortalized human Jurkat T 
cells, treated with staurosporine, as apoptotic targets. Jurkat T cells have been widely 
used because of their small size and they are easy to culture79. Previous studies used 
staurosporine, a general inhibitor of cellular serine/threonine kinase, to induce apoptosis 
in these cells via a caspase 9 dependent pathway80. Annexin V staining was used to 
confirm that PtdSer was being flipped to the outer leaflet of the apoptotic cells plasma 
membrane81 and images of apoptotic Jurkat T cells were acquired by widefield 
microscopy. As a positive control I used ionomycin, a Ca2+ ionophore, to induces PtdSer 
exposure independent of apoptosis82. As expected, ionomycin treated Jurkat T cells 
stained strongly with annexin V (Figure 2A). Apoptotic Jurkat T cells also stained with 
annexin V (Figure 2B), whereas control Jurkat T cells were negative for annexin V 
staining (Figure 2C). However, staurosporine generated a low yield of apoptotic cells 
after 2.5 hours, and longer incubation periods were avoided in order to prevent the 
formation of necrotic cells. This data demonstrates that PtdSer can be used to detect 
apoptosis in our model systems, but staurosporine was inefficient to produce apoptotic 
targets. 
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Figure 2: Staurosporine (STS) induction of apoptosis in Jurkat T cells. 
The apoptosis marker PtdSer was stained on Jurkat T-cells using fluorescent annexin V 
(red). A) PtdSer flipping was induced in Jurkat T cells with ionomycin. Scale bar = 20 
µm. B) PtdSer flipping was observed on cells in which apoptosis was induced with STS. 
C) No PtdSer flipping was observed on untreated cells. Jurkat T cells are marked by 
arrows. Images are representative of 3 images, taken over 3 independent experiments.  
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I then tested an alternative method that has been used in the literature to reliably produce 
a large percentage of apoptotic cells without significant necrosis. This model utilizes 
heat-shocked human neutrophils. Human neutrophils undergo rapid apoptosis in a 
caspase-dependent manner by the heat-shock treatment (>40°C)83. Using the method of 
Park et al.75, (details in Section 2.4) I achieved a stronger induction of apoptosis with a 
high yield (>40%) of apoptotic neutrophils without producing overt signs of secondary 
necrosis such as cell fragmentation. As expected, apoptotic neutrophils were annexin V 
positive and propidium iodide negative, indicating the absence of significant necrosis 
(Figure 3A). The positive staining control, necrotic neutrophils, stained with both annexin 
V and propidium iodide (Figure 3B). Because the method of Park et al. provided high 
rates of apoptosis in neutrophils without necrosis it was used for all future experiments 
requiring apoptotic cells.   
Next I assessed the efferocytic capabilities of the J774.2, RAW264.7 and ANA-1 murine 
macrophage cell lines. Prior to the efferocytosis assay, I transfected these cells with 
plasma membrane tagged GFP (pmGFP) to identify efferosomes through the formation of 
a GFP+ (e.g. plasma membrane-derived) intracellular vacuole84. These cells then became 
apoptotic neutrophils that were pre-labeled with the fluorescent cell tracer eFluor670. At 
the end of the experiment non-efferocytosed neutrophils were labeled with an anti-human 
CD18 antibody and Cy3-conjugated secondary antibody. Negative immunostaining of 
CD18 indicates that a neutrophil was completely engulfed. Images of J774.2 cells, were 
acquired by confocal microscopy and revealed a number of neutrophil-containing 
vacuoles with GFP in their bounding membrane, indicating efferocytosis had occurred 
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Figure 3: Generation of apoptotic neutrophils by heat-shock. 
Apoptosis and necrosis was induced in human polymorphonuclear neutrophils by heat-
shock, and the cells stained with annexin V (green, merged channel) and propidium 
iodide (red, merged channel). A) Apoptotic neutrophils stained with annexin V but not 
propidium iodide. Scale bar = 10 µm. B) Necrotic cells stained with both annexin V and 
propidium iodide.  Image is representative of 3 images, taken over 3 independent 
experiments.  
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Figure 4: J774.2 cells efferocytose apoptotic neutrophils. 
J774.2 macrophages were transfected with pmGFP (green) and efferocytosed eFlour670-
labeled apoptotic neutrophils (red). Non-efferocytosed neutrophils were labeled with anti-
CD18 (cyan). Insert highlights an efferocytosed neutrophil which is CD18-negative, and 
surrounded by a pmGFP-positive bounding membrane.  Image is representative of 15 
images, taken over 3 independent experiments. Scale bar = 10 µm. 
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within 10 minute timeframe of the assay (Figure 4). All neutrophils observed in GFP+ 
compartments were not labelled with anti-CD18, demonstrating that J774.2 cells 
efficiently and completely internalized the apoptotic cells. Similar experiments were 
performed with ANA-1 and RAW264.7 cells, however these cells have extremely low 
levels of efferocytosis (less than 1 neutrophil engulfed per field of view (~20 cells), data 
not shown) and were not be used for future experiments. 
3.2 Optimized In Vitro Efferocytosis Assay of Synthetic 
Apoptotic Targets 
Although apoptotic human neutrophils were efferocytosed, the number of efferocytosed 
apoptotic cells was limited (~0.5/transfected J774.2 cell). Moreover, neutrophils were not 
always available due to limited blood donors. As such it was necessary to generate 
apoptotic cell mimics that would be consistently efferocytosed in greater numbers and 
which could be prepared as needed. I took a bead-based approach which is commonly 
used in studies of phagocytosis and efferocytosis, and which is established to generate 
more stable and reproducible phagocytic/efferocytic targets34, 76. Silica beads were coated 
with phospholipids to mimic plasma membranes of apoptotic cells by coating them with a 
mixture of PtdSer (20%) and PtdCho (80%). If required, 0.2% of the PtdSer could be 
replaced with biotinylated phosphatidylethanolamine (Biotin-PtdEtn) to allow detection 
of non-internalized beads with fluorescent streptavidin76. To ensure that efferocytosis is 
PtdSer specific, control beads containing PtdCho (with or without Biotin-PtdEtn) were 
also prepared. pmGFP transfected J774.2 cells efficiently internalized these apoptotic  
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Figure 5: J774.2 cells efferocytose apoptotic cell-mimicking beads. 
pmGFP-expressing J774.2 macrophages (green) were fed PtdSer/PtdCho or PtdCho 
(negative control) coated beads. Streptavidin (red) was used to detect non-internalized 
beads. A) J774.2 macrophages efferocytosed apoptotic cell mimics (arrows).  B) J774.2 
cells did not phagocytose PtdCho beads. Scale bars = 10 µm. C) Phagocytic index of 
J774.2 cells efferocytosing apoptotic cell mimics. Data shown at means ± SEM, n=4. **, 
p<0.05.  
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cell mimics but not the control (PtdCho) beads (Figure 5A). Efferosomes that were 
surrounded by a ring of GFP were not marked with streptavidin, indicating they were 
internalized into a membrane-bound compartment within the macrophage. Partially 
internalized and surface bound PtdSer-coated beads labeled with fluorophore-conjugated 
streptavidin (Figure 5A). The efferocytic capacity (phagocytic index) of J774.2 cells was 
calculated by dividing the total number of internalized beads by the total number of 
J774.2 cells. On average two PtdSer-coated beads were efferocytosed per J774.2, 
whereas no PtdCho coated beads were internalized (Figure 5B). This data demonstrates 
that these apoptotic mimics are a viable alternative to apoptotic neutrophils.  
3.3 In Vitro Efferocytosis by Primary Human Macrophages 
Because cell lines are prone to mutations that impact in downstream cellular processes, 
we wished to establish an efferocytosis assay using primary human macrophages. To 
accomplish this I quantified the efferocytosis ability of primary human macrophages 
differentiated to the three main subtypes of macrophages. M0 macrophages (cultured 
with M-CSF alone) are fully matured but non-polarized macrophages. M1 macrophages 
(cultured with GM-CSF, IFN-γ and LPS) and M2 macrophages (cultured with M-CSF 
and IL-4) are highly pro-inflammatory macrophages and anti-inflammatory/tissue healing 
macrophages respectively12, 17. Each subtype was fed PtdSer-coated or PtdCho-coated 
beads for 30 minutes and imaged by fluorescent microscopy to calculate phagocytic 
index. 
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M0 macrophages readily internalized PtdSer-coated beads whereas no PtdCho-coated 
beads were engulfed (Figure 6). M1 macrophages did not internalize many beads, and 
internalized both PtdSer and PtdCho beads with equal efficiency (Figure 6), suggesting 
that this uptake was non-specific. M2 macrophages actively efferocytosed PtdSer-coated 
beads but to a lesser extent than M0 macrophages (Figure 6). This data suggests that M0 
and M2 macrophages are effective in internalizing apoptotic cells, while M1 
macrophages are not. However, as M0 cells had the highest efferocytic capacity, we 
selected them for use in future aims. 
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Figure 6: Efferocytosis by primary human macrophages  
Human monocytes were differentiated into M0, M1 and M2 macrophages. Polarized 
macrophages were fed PtdSer-coated beads and PtdCho-only coated beads, and the 
phagocytic index was quantified. n = 4, **, p < 0.05 compared to PtdCho-only beads. 
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3.4 Efferosomes Acquire Rab5 and Rab7 Similarly to 
Phagosome Maturation 
Using the highly effective bead-based model, I next assessed the role of Rab5 and Rab7, 
phagosome maturation regulators, in efferosome maturation using J774.2 cells. 
Specifically, I assessed whether both phagosomes and efferosomes recruited these 
common regulators of phagosome maturation as the C. elegans studies51, or if 
efferosomes only recruit Rab5 as suggested by our preliminary results and the dendritic 
cell studies64, 65. To this end I tracked ectopically expressed GFP- or mCherry-tagged 
Rab5 and Rab7, which demark early and late stages of maturation respectively10, 52, in 
J774.2 cells engulfed IgG-coated or PtdSer-coated beads. Phagocytosis of IgG opsonized 
beads was used as a positive control, and exhibited the expected pattern of Rab5/Rab7 
acquisition wherein Rab5 was recruited at 10 minutes and replaced at later time points by 
Rab7 GTPases  (Figure 7, 11A). By 20 minutes most phagosomes were Rab5 negative 
and had acquired Rab7, with Rab7 completely replacing Rab5 on the phagosomes by 30 
minutes (Figure 7, 11A). This data confirms that J774.2 cells demonstrate normal 
phagosome maturation, with dynamics similar to that reported in other types of 
macrophages51. 
This assay was repeated using apoptotic cell mimics (Figure 8, 11B).  By 10 minutes 
efferosomes had recruited Rab5 GTPases, but the Rab5 began to disappear at 20 minutes, 
with Rab5 completely lost from the efferosomal membrane by 30 minutes (Figure 8, 
11B). Rab7 began to appear on the efferosomal membrane as early as at the 10 minute 
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time-point, with significant recruitment observed at 20 minutes.  Rab7 entirely replaced 
Rab5 on the efferosome membrane by 30 minutes (Figure 8, 11B).  
To confirm that the observed patterns of Rab acquisition were not due to artefacts created 
by using lipid-coated beads we repeated these experiments using apoptotic neutrophils. 
Apoptotic neutrophils were readily internalized, and the resulting efferosomes positive 
for Rab5 by the 10 minute time-point, with the Rab5 displaced within 20 minutes (Figure 
9, 11C) and replaced by Rab7 (Figure 10, 11C). Rab5 was completely supplanted from 
the efferosome by Rab7 after 30 minutes (Figures 9, 10, 11C). The acquisition of Rab5 
and Rab7 during efferocytosis in both the bead-based and cell-based strongly suggests 
this is a bona fide result and not an artefact of the apoptotic bead model. 
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Figure 7: Tracking Rab5 and Rab7 on phagosomes  
Rab5-GFP (green) /Rab7-mCherry (red) transfected J774.2 cells were fed IgG-coated and 
imaged at various time points. Non-internalized beads were labeled with the fluorophore-
tagged secondary antibody (magenta). Image is representative of 20 images, taken over 3 
independent experiments. Scale bars = 5 µm. 
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Figure 8: Tracking Rab5 and Rab7 on efferosomes 
Rab5-GFP (green)/Rab7-mCherry (red) transfected J774.2 cells were fed PtdSer-coated 
beads and imaged at different time points. Non-internalized beads were labeled with 
streptavidin (magenta) at the end of the experiment. Image is representative of 20 images, 
taken over 3 independent experiments. Scale bars = 10 µm. 
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Figure 9: Rab5 recruitment to apoptotic-neutrophil containing efferosomes. 
Rab5-GFP transfected (green) J774.2 cells efferocytosed apoptotic neutrophils labeled 
with eFluor670 (red) and were imaged at different time points. Non-internalized 
neutrophils were immunostained with anti-CD18 (cyan) at the end of the experiment. 
Image is representative of 16 images, taken over 3 independent experiments. Scale bar = 
10 µm. 
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 Figure 10: Rab7 recruitment to apoptotic-neutrophil containing efferosomes. 
Rab7-GFP transfected J774.2 cells (green) efferocytosed apoptotic neutrophils labeled 
with eFluor670 (red) and were imaged at different time points. Non-internalized 
neutrophils were immunostained with anti-CD18 (cyan) at the end of the experiment. 
Image is representative of 16 images, taken over 3 independent experiments. Scale bar = 
10 µm. 
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Figure 11: Quantification of Rab5 and Rab7 on phagosomes and efferosomes. 
Rab GTPases mediated maturation process was eluciated by the quantification of Rab5 
and Rab7 on phagosomes/efferosomes in each maturation stages. A) The presence of 
Rab5/7 on IgG beads containing phagosomes in each time frame was quantified by 
dividing numbers of Rab5 or Rab7 positive-structures by the total number of 
phagosomes. The presence of Rab5/7 on  B) PtdSer beads and C) apoptotic neutrophils 
containing efferosomes in each time frame was quantified by dividing numbers of Rab5 
or Rab7 positive-structures by the total number of efferosomes. Phagosomes/efferosomes 
were counted from two successful independent experiments. 
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3.5 Efferosomes Undergo Fusion with Lysosomes 
Although the J774.2 murine macrophages cell line revealed that efferosomes recruited 
Rab5 and Rab7 in a similar manner to phagosomes, the possibility remains that this is an 
artefact of the cell line we are using, thereby primary macrophages were employed to 
assess efferosome maturation. At present we cannot transfect primary human 
macrophages. Thus, to assess efferosome maturation in primary human macrophages I 
immunostained for LAMP-1, a maturation marker that is delivered to phagosomes 
through Rab7-mediated fusion of the phagosome with late endosomes and lysosomes73. 
M0 macrophages were fed IgG-coated beads (Figure 12A), PtdSer-coated beads (Figure 
12B) or eFluor670 labeled apoptotic neutrophils (Figure 12C) for 30 minutes and then 
immunostained for LAMP-1. This time point was chosen as our previous results 
indicated that Rab7 completely replaced Rab5 by this time on efferosomal and 
phagosomal membranes (Figures 7 to 11). LAMP-1 was observed on both the 
phagosomal and efferosomal membranes, confirming that efferosomes were undergoing 
the classical Rab5-Rab7 maturation process like that utilized by phagosomes.  
3.6 Identification of Regulator Proteins on Efferosomes 
Although both phagosomes and efferosomes appear to utilize the same maturation 
process, the different immunological outcomes of phagocytosis (inflammation, 
immunogenic antigen presentation) and efferocytosis (homeostasis, no or tolerogenic 
antigen presentation) indicates that the degraded materials in efferosomes is treated 
differently than in phagosomes. These differences likely occur in the latest stages of the  
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Figure 12: M0 macrophages fuse lysosomes to efferosomes. 
Human M0 macrophages phagocytosed A) IgG-coated beads marked by asterisks, B) 
PtdSer-coated beads marked by asterisks, or C) apoptotic neutrophils labeled with 
eFlour670 (red), for 30 minutes. Cells were then fixed and immunostained for LAMP-1 
(green). Images are representative of 14 images, taken over 2 independent experiments. 
Scale bars = 10 µm. 
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maturation process, after lysosomal fusion. To identify these novel processes an unbiased 
mass spectrometry analysis was implemented using M0 macrophages and magnetic 
PtdSer-coated beads. A longer time frame of efferocytosis (40 minutes) was used to 
ensure that the majority of efferosomes reached the Rab7/LAMP-1 positive (late) stage of 
maturation. For comparison, phagosomes containing IgG coated magnetic beads were 
isolated at the same time point. To maximize protein recovery I implemented the 
reversible cross-link immune-precipitation (ReCLIP) technique which provided better 
protein recovery by using two protein cross-linking reagents, Dithiobis (succinimidyl 
propionate) and Dithio-bismalemidoehane, to the cells prior to lysis (data not shown)78. 
Following lysis, a magnetic column was used to recover the efferosomes and phagosomes, 
and SDS-PAGE used to separate the recovered proteins. Coomassie staining revealed 
multiple unique protein bands in both the efferosome and phagosome isolates (Figure 13, 
arrows). Notably, the total amount of recovered proteins from efferosomes was less than 
recovered from phagosomes, likely due to higher levels of phagocytosis than 
efferocytosis in unpolarized M0 macrophages. 
Bands of interest were excised from the gel and the proteins identified with mass 
spectrometry and MASCOT software analysis of the resulting spectra. Proteins with a 
MASCOT matching score greater than 40 were considered to be very high-quality hits, 
matching scores of 30 – 40 were considered to be high quality hits, and matching score of 
20-30 considered medium-quality hits (Tables 4, 5).  Proteins with scores below 20 were 
not considered to be significant. Several interesting proteins were recovered from 
efferosomes with high quality or better scores (score >30, Table 4),  
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Figure 13: Multiple unique proteins were recovered from efferosomes and 
phagosomes.  
PtdSer/PtdCho-coated magnetic beads (efferosome) and IgG-coated magnetic beads 
(phagosome) were used as efferocytic targets and recovered from M0 primary human 
macrophages at 40 minutes post-internalization. Unique protein bands on each sample are 
marked by arrows. Image is representative of 3 independent experiments. 
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including regulators of vesicular traffic (Rab1785, RASEF (Rab45)86 and VPS33B87), an 
inhibitory phosphatase of MAP Kinase signaling (PP2A)88, the efferocytic receptor 
CD3622, a number of actin-regulatory proteins (WIPF3, Rac2 and Talin)49, a negative 
regulator of phosphatidylinositide signaling (IMPA2)89, and proteins involved in 
ubiquitination (TRIM25, USP15)90, 91. Both MHC I and MHC II92 were identified as 
medium-quality hits (score of 20-30, Table 4). Phagosomes recruited a very different 
network of proteins. Among the high quality hits (score > 30, Tables 5) were both MHC I 
and MHC II92, regulators of Golgi export (Rab6b and PI4-Kinase)93, 94, a number of 
protein kinases (MKNK1, MINK1, STK4, PRKAB1)95, 96, 97, 98, the pattern recognition 
receptor modulator NLRP3 (NOD3)99, 100, 101, as well as a number regulators of calcium 
signaling (INPP5A and STRN3)102, 103.  Although numerous hits identified interesting 
proteins on both efferosomes and phagosomes, future studies using biochemical or cell 
based assays are required to validate these hits and test for the function of these proteins 
during efferosome and phagosome maturation. 
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Table 4: Summary of all proteins detected by mass spectrometry analysis of isolated 
efferosomes.   
“Protein Name” and “Protein Symbol” indicate the official gene name listed in the NCBI 
database, and “NCBI Accession Number” indicates the specific entry in the NCBI gene 
catalogue corresponding to the identified peptides. “Protein Score” indicates the quality 
of the match, based on the Mascot software scoring system. “# peptides” indicates the 
total number of peptides from each protein identified. “Total residues” indicates the total 
number of amino acid residues identified across all peptides. “% Coverage” indicates the 
portion of the total protein identified by mass spectrometry. Data is the aggregate of 3 
experiments.   
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Very	  High	  Quality	  Hits	  (MASCOT	  Score	  >	  40)	    
Protein	  Name	   Protein	  Symbol 
NCBI	  Accession	  
Number	  
Protein	  
Score	  
#	  
peptides	  
Total	  
residue	  
%	  
Coverage	  
Size	  
	  (kD)	  
Talin	  1	   TLN1 XP_005251621	   67	   198	   2541	   7.79	   270	  
Tripartite	  motif-­‐containing	  25	   TRIM25 EAW94523	   52	   85	   422	   20.1	   71	  
MAP4	  protein	   MAP4 AAH48200	   51	   119	   857	   13.9	   121	  
Ubiquitin	  specific	  peptidase	  15	   USP 15 AAI25124	   48	   115	   952	   12.1	   112	  
Leucine	  rich	  repeat	  neuronal	  1	   LRRN1 EAW63901	   46	   48	   84	   57.1	   81	  
Galectin	  3	   LGALS3 1KJL_A	   46	   69	   146	   47.3	   26	  
Inositol	  monophosphatase	  A2b	   IMPA2 AAF07824	   45	   72	   261	   27.6	   31	  
Ras-­‐related	  protein	  Rab-­‐17	   RAB17	   XP_006712752	   45	   69	   190	   36.3	   23	  
PTPRF	  interacting	  protein	  1	   PPFIP1	   AAH46159	   45	   86	   272	   31.6	   114	  
F-­‐box	  protein	  Fbx6	  	   FBX6	   AAF04470	   43	   74	   338	   21.9	   34	  
PTGFRN	  protein	   PTGFRN	   AAH98142	   40	   89	   788	   11.3	   99	  
High	  Quality	  Hits	  (MASCOT	  Score	  30	  -­‐	  40)	   	  
Protein	  Name	   Protein	  Symbol	  
NCBI	  Accession	  
Number	  
Protein	  
Score	  
#	  
peptides	  
Total	  
residue	  
%	  
Coverage	  
Size	  
	  (kD)	  
Vacuolar	  protein	  sorting-­‐
associated	  protein	  33B	   VPS33B	   XP_003807753	   39	   95	   590	   16.1	   71	  
Serine/threonine-­‐protein	  
phosphatase	  2A	  
PP2A	   NP_060387	   37	   46	   453	   10.2	   56	  
WAS/WASL-­‐interacting	  protein	  
family	  member	  3-­‐like	   WIPF3	   XP_005276342	   35	   48	   326	   14.7	   49	  
Rac2	   RAC2	   P15153	   34	   19	   148	   12.8	   21	  
Glycogen	  synthase	  kinase	  3-­‐
beta	  
GSK3B	   P49841	   33	   18	   18	   100	   47	  
Mannin-­‐binding	  lectin	  serine	  
protease	  1	   MASP1	   AAO85801	   33	   13	   84	   15.5	   79	  
RASEF	  (Rab45)	   RASEF	   Q8IZ41	   32	   32	   44	   72.7	   83	  
CD36	   SCARB1	   AAG60629	   30	   18	   31	   58.1	   61	  
Medium	  Quality	  Hits	  (MASCOT	  Score	  20	  –	  30)	   	  
Protein	  Name	   Protein	  Symbol	  
NCBI	  Accession	  
Number	  
Protein	  
Score	  
#	  
peptides	  
Total	  
residue	  
%	  
Coverage	  
Size	  
	  (kD)	  
Liver	  alkaline	  phosphatase	   ALPL	   AAB24485	   29	   10	   15	   66.7	   57	  
MHC	  class	  II	  antigen	  
HLA-­‐
DPB1	   AEB91578	   29	   27	   177	   15.3	   29	  
Calsyntenin	  2	   CLSTN2	   EAW79017	   27	   49	   608	   8.06	   107	  
MAP	  kinase	  interacting	  
serine/threonine	  kinase	  1	   MKNK1	   EAX06901	   22	   12	   227	   5.29	   51	  
MHC	  Class	  I	   MR1	   AAB22522	   22	   8	   90	   8.89	   43	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Table 5: Summary of all proteins detected by mass spectrometry analysis of isolated 
phagosomes.   
“Protein Name” and “Protein Symbol” indicate the official gene name listed in the NCBI 
database, and “NCBI Accession Number” indicates the specific entry in the NCBI gene 
catalogue corresponding to the identified peptides. “Protein Score” indicates the quality 
of the match, based on the Mascot software scoring system. “# peptides” indicates the 
total number of peptides from each protein identified. “Total residues” indicates the total 
number of amino acid residues identified across all peptides. “% Coverage” indicates the 
portion of the total protein identified by mass spectrometry. Data is the aggregate of 3 
experiments. 
  
77 
 
 
 
Very	  High	  Quality	  Hits	  (MASCOT	  Score	  >	  40)	  
Protein	  Name	   Protein	  Symbol	  
NCBI	  Accession	  
Number	  
Protein	  
Score	  
#	  
peptides	  
Total	  
residue	  
%	  
Coverage	  
Size	  
	  (kD)	  
CTTNBP2	  N-­‐terminal-­‐like	  protein	  	   CTTNBP2NL	   	  Q9P2B4	   61	   204	   658	   31.0	   70	  
MHC	  class	  I	  antigen	   MR1	   AFZ93953	   58	   62	   181	   34.3	   39	  
Insulin-­‐like	  growth	  factor	  binding	  
protein	  2	  
IGFBP2	   AAA36048	   54	   126	   325	   38.8	   35	  
Misshapen-­‐like	  kinase	  1	   MINK1	   Q8N4C8	   52	   91	   1298	   7.01	   150	  
Acylphosphatase-­‐1	  	   ACYP1	   P07311	   45	   37	   85	   43.5	   11	  
MHC	  Class	  II	   HLADQB1	   AGW82950	   44	   58	   261	   22.2	   30	  
Cyclin-­‐Y-­‐like	  protein	  2	   CCNYL2	   XP_006710109	   41	   58	   174	   33.3	   41	  
Lymphoid	  enhancer-­‐binding	  factor	  1	   LEF1	   Q9UJU2	   40	   89	   303	   29.4	   44	  
RalA	  binding	  protein	  1	   RALBP1	   BAD93161	   40	   82	   462	   17.7	   76	  
Serine/threonine-­‐protein	  kinase	  4	   STK4	   Q13043	   40	   29	   274	   10.6	   56	  
High	  Quality	  Hits	  (MASCOT	  Score	  30	  -­‐	  40)	  
Protein	  Name	   Protein	  Symbol	  
NCBI	  Accession	  
Number	  
Protein	  
Score	  
#	  
peptides	  
Total	  
residue	  
%	  
Coverage	  
Size	  
	  (kD)	  
Annexin	  A2	   ANXA2	   P07355	   39	   57	   287	   19.9	   39	  
MAP	  kinase-­‐interacting	  
serine/threonine-­‐protein	  kinase	  1	  	   MKNK1	   XP_006711064	   38	   78	   418	   18.7	   51	  
BCR-­‐ABL	  fusion	  protein	   BCR/ABL	   A9UF05	   34	   46	   101	   45.5	   51	  
PIK4	  Kinase	   PIK4	   P42356	   34	   56	   278	   20.1	   231	  
Cytotoxic	  T-­‐lymphocyte	  protein	  4	   CTLA4	   P16410	   34	   46	   174	   26.4	   25	  
Type	  I	  inositol-­‐1,4,5-­‐trisphosphate	  5-­‐
phosphatase	  
INPP5A	   Q14642	   34	   30	   31	   96.8	   48	  
RAB6B	  protein	   RAB6B	   Q9NRW1	   34	   83	   208	   39.9	   23	  
Abhydrolase	  domain	  containing	  1	   ABHD1	   Q96SE0	   33	   63	   186	   33.9	   45	  
Lactate	  dehydrogenase	  c	   LDHC	   P07864	   33	   41	   96	   42.7	   36	  
Striatin,	  calmodulin	  binding	  protein	  3	   STRN3	   Q13033	   31	   48	   445	   10.8	   87	  
NOD3	  protein	   NLRC3	   EAW85349	   30	   111	   717	   15.5	   114	  
5'-­‐AMP-­‐activated	  protein	  kinase	  
beta-­‐1	   PRKAB1	   Q9Y478	   30	   15	   248	   6.05	   30	  
Medium	  Quality	  Hits	  (MASCOT	  Score	  20	  -­‐	  30)	  
Protein	  Name	   Protein	  Symbol	  
NCBI	  Accession	  
Number	  
Protein	  
Score	  
#	  
peptides	  
Total	  
residue	  
%	  
Coverage	  
Size	  
	  (kD)	  
GTPase	  IMAP	  family	  member	  GIMD1	   GIMD1	   P0DJR0	   27	   24	   217	   11.1	   24	  
Cyclin-­‐dependent	  kinase	  4	   CDK4	   P11802	   26	   20	   111	   18.0	   34	  
DOCK10	  protein	   DOCK10	   Q96BY6	   26	   58	   542	   10.7	   250	  
CKLF-­‐like	  MARVEL	  transmembrane	  
domain-­‐containing	  protein	  1	   CMTM1	   Q8IZ96	   23	   14	   122	   11.5	   19	  
Interferon-­‐stimulated	  20	  kDa	  
exonuclease-­‐like	  2	  	  
ISG20L2	   Q9H9L3	   20	   12	   138	   8.70	   39	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Chapter 4 - Discussion 
4.1 Rational of the Thesis: Efferosome Maturation 
Pathways and the Immune System 
Billions of cells undergo programmed cell death every day in our bodies, and those 
apoptotic cells must be cleared by efferocytosis. If left uncleared, severe autoimmune and 
chronic inflammation can occur following the release of pro-inflammatory and 
immunogenic materials through secondary necrosis66. During efferocytosis professional 
phagocytes remove apoptotic cells in an anti-inflammatory manner. In contrast, 
phagocytosis - a part of the innate immune system - produces pro-inflammatory 
responses after engulfing pathogens11. Despite these differences in the immunological 
outcome of efferocytosis and phagocytosis, the two processes share a common 
degradative pathway mediated by Rab GTPases and fusion events between the forming 
efferosome/phagosome and vesicles from the endocytic pathway. This differential 
regulation of the outcomes of phagocytosis versus efferocytosis is the key for maintaining 
homeostasis under inflammatory versus homeostatic circumstances. Efferocytosis can be 
divided to three discrete but sequential stages: 1) recruitment of phagocytes to “find-me” 
signals secreted by apoptotic cells, 2) binding and internalization of the apoptotic cell by 
engagement of “eat-me” signals by phagocyte receptors, and 3) degradation of the 
apoptotic cell via maturation of the efferosome. The maturation process of efferocytosis 
has been primarily studied in C. elegans, and much of what is known of this process has 
been derived from these studies51. Many proteins involved in efferosome formation and 
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maturation, such as CED/Rac and Rab 5/7 are evolutionarily conserved between 
nematodes and mammals51, implying that they may serve a common function in 
efferocytosis in both groups of organisms. However several observations suggest that 
efferocytosis has distinct outcomes between these organisms, suggesting that the 
regulation of efferocytosis - or its outcomes - has evolved differently between these two 
groups of organisms.  
For example, Rab5 activation was inhibited by a lack of Gapex-5, a Rab5 GEF, near the 
site of apoptotic cell engagement in a mammalian system but not in C. elegans104. 
Moreover, efferocytosis is anti-inflammatory while phagocytosis is pro-inflammatory in a 
mammalian system, but both the inflammatory and antigen presentation portions of these 
responses do not exist in C. elegans105, 106. In addition, recent studies of mammalian 
efferocytosis have identified several novel processes not observed in C. elegans. For 
example, Balce et al. revealed that alternately activated M2 mammalian macrophages 
showed reduced NADPH oxidase activity in efferosomes, distinct from what is observed 
in C. elegans efferosomes and mammalian phagosomes18. Indeed, the C. elegans 
efferocytic pathway more closely parallels mammalian phagocytosis pathways than it 
does the mammalian efferocytic pathway51. Moreover, studies of dendritic cells suggest 
that mammalian efferocytosis may not proceed past the Rab5 stage64, 65, although the 
results of this thesis (Figure 7 to 10) would suggest this is a DC-cell specific 
phenomenon. Combined, these studies suggest that the mammalian efferocytosis pathway 
is regulated differentially from efferocytosis in C. elegans and mammalian phagocytosis, 
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thus allowing it to produce the cellular responses key to preventing chronic inflammation 
and autoimmunity downstream of apoptotic cell removal. 
4.2 Hypothesis and Aims 
How these molecular mechanisms controlling mammalian efferosome formation and 
maturation are anti-inflammatory/anti-immunogenic are not fully understood. For this 
thesis, because efferocytosis and phagocytosis have different inflammatory and 
immunogenic outcomes, I hypothesized that phagocytic and efferocytic maturation 
pathways are regulated by fusions with different intracellular compartments, and that 
these fusion events are regulated by novel mediators recruited either to phagosomes or to 
efferosomes. The following research aims were designed to elucidate whether efferosome 
maturation was unique, using cell biology and biochemical assays: 1) establish an in vitro 
macrophage model of efferocytosis, 2) characterize the acquisition of common 
maturation markers (i.e. Rab5, Rab7, LAMP-1) of phagocytosis to efferosomes, and 3) 
identify potential novel regulators on efferosomes and phagosomes by mass 
spectrometry. 
4.3 Development of an In Vitro Efferocytosis Model 
All aims of this study required an in vitro efferocytosis model that required both a 
consistent and reproducible efferocytic target and a cell line that exhibited strong and 
consistent efferocytosis. Generation of apoptotic cells is preferable for studying 
efferocytosis as they most closely mimic the in vivo environment, and several methods 
have been used by other researchers to induce consistent and high rates of apoptosis for 
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these types of assays107, 108. Previous models have included UV exposure, anti-cancer 
drugs (e.g. Staurosporine), and physical stresses such as heat-shock or cold-shock 
treatment107, 108, 109. Several previous studies adopted staurosporine, an inhibitor of 
multiple kinases, to induce apoptosis via activation of caspase 3108, 110. However, in my 
hands STS did not generate a sufficient number of apoptotic Jurkat T cells for my 
experiments (Figure 1B). To improve on this I utilized another popular model, the heat-
shocked induce apoptosis of primary human neutrophils75. This induced high rates of 
apoptosis in isolated treated neutrophils without measurable necrosis (Figure 2). These 
apoptotic neutrophils were readily efferocytosed by J774.2 macrophages, demonstrating 
that they are good efferocytic targets (Figure 3).  
While the neutrophil-based efferocytosis assay was successful, the availability of 
neutrophils was limited. Moreover, these apoptotic neutrophils would not have been 
suitable targets for mass spectrometry as it would not be possible to separate proteins 
derived from the apoptotic neutrophils from those found on the recovered efferosomes. 
As such I developed a bead-based efferocytosis model which provides simple and highly 
reproducible apoptotic targets. This method was based on of similar targets developed by 
other groups, but was modified to allow for detection of non-internalized versus 
internalized beads through the incorporation of biotinylated PtdEtn111, 34, 76. These 
efferocytotic targets consisted of silica beads coated with 20% PtdSer and 80% PtdCho 
that mimic apoptotic cell membranes, while beads coated with only PtdCho were used to 
mimic healthy cells. When required, 0.2% of these lipids were substituted with biotin-
PtdEtn to allow for detection of non-internalized beads through the addition of 
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fluorescently labeled streptavidin. As expected, macrophages only efferocytosed PtdSer-
coated beads, indicating these were a good model for our PtdSer specific efferocytosis 
studies (Figure 4). 
In addition to reproducible efferocytic targets, this thesis also required the identification 
of macrophage cell lines or primary macrophage subtypes which consistently engage in 
efferocytosis. To generate reproducible in vitro model of efferocytosis I utilized J774.2 
and M0 primary human macrophages, which consistent with previous studies, were 
determined to have high efferocytic capacities (Figures 3, 4)34, 35, 74. While the 
RAW264.7 cell line is the most frequently used cell line for phagocytosis studies, 
especially studies of phagosome maturation and vesicular trafficking112, 113, I determined 
that RAW264.7 and the related ANA-1 cell lines did not internalize PtdSer-coated beads 
(data not shown). The differences between the efferocytic capacity of the J774.2 and M0 
macrophages versus the ANA-1 and RAW264.7 cell lines is unclear, but I would 
hypothesize that each cell line expresses different levels of efferocytic receptors. 
Consistent with this hypothesis are studies showing RAW264.7 cells have low expression 
of TIM-4114 and CD36115. In contrast, previous studies have also found J774.2 cell have a 
high efferocytic capacity, provided by the expression of the receptors for calreticulin and 
PtdSer35, 116. Importantly, Figures 4 and 5 demonstrate that macrophages recognized and 
internalized only PtdSer-coated beads, but not PtdCho only coated beads, indicating 
uptake was specific to the inclusion of the PtdSer “eat-me” signal in these beads. This 
specificity may have been provided by expression of the PtdSer specific receptor TIM-4 
on J774.2 and M0 macrophages34, 116. Indeed, TIM-4-/- bone marrow-derived 
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macrophages (BMDM) showed dramatically reduced internalization of PtdSer-coated 
beads in absence of any opsonins, while TIM-4+/+ wild-type primary macrophages 
showed extensive uptake of PtdSer-coated beads but not PtdCho beads34. Critically, this 
study demonstrates that the recognition of “eat-me” signals in targets containing a mixed 
lipid composition is specific to the presence of the eat-me signals present on the beads.  
4.4 Macrophage Subtypes and Efferocytosis 
Differences in the immunological responses generated by M0, M1 and M2 primary 
human macrophages provide insights into their efferocytic capacities. M0 macrophages 
resemble the macrophages which patrol healthy tissues, M1 macrophages are 
conventional pro-inflammatory cells found at sites of pathogen invasion, and M2 
macrophages are alternatively polarized for anti-inflammatory actions such as wound 
healing and tissue remodeling12, 13. Figure 5 demonstrates the efferocytic capacities of 
each subtype. M0 and M2 macrophages could efferocytose PtdSer-coated beads, whereas 
M1 macrophage rarely efferocytosed PtdSer-coated beads. Moreover, the uptake of beads 
in M1 cells was not PtdSer-specific, suggesting the observed uptake may have been 
chance capture due to the high levels of membrane ruffling and spontaneous membrane 
enclosing observed in these cells117. These results followed our predictions, as M2 cells 
would require higher efferocytic capacities in order to clear dying cells from wound sites, 
M0 macrophages would be expected to engage in efferocytosis are part of their 
“housekeeping” activities, while neither of these functions would be required by M1 cells 
attempting to restrict an infection. Unexpectedly, the highest phagocytic index (12.5) was 
observed in M0 macrophages, not M2 cells, suggesting that in vivo these M0 cells must 
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frequently encounter apoptotic cells, suggesting they play a more central role in 
homeostasis than previously thought. Indeed, most tissue resident macrophages are 
thought to have an M0 phenotype16, suggesting that the bulk of homeostatic efferocytosis 
may be performed by these cells rather than by other efferocytic cell types such as 
epithelial cells118. 
4.5 Role of Rab5 and Rab7 in Efferosome Maturation 
Previously, efferosome maturation was characterized in studies of C. elegans, specifically 
assaying the removal of the apoptotic cells produced during C. elegans’ development 
process51. C. elegans and mammals evolutionarily share many parts of the proteins 
regulating phagosome maturation, including the “master regulatory” Rab GTPases and 
phosphatidylinositol kinases that regulate much of the maturation process51. Tracking 
these protein regulators during C. elegans phagocytosis of apoptotic cell revealed a 
process similar to mammalian phagocytosis of pathogens – namely, Rab5 was recruited 
to early efferosomes and then supplanted by Rab7 in the later stages51. Moreover, this 
study also demonstrated that the small GTPases CED-10 and Rac played a similar role in 
in the internalization of apoptotic cells in both mammalian and C. elegans phagocytes. 
Upon receptor engagement of apoptotic targets, CED-10 and Rac transmit downstream 
signals to induce membrane ruffles and protrusion, driven by actin remodeling, in order 
to engulf the apoptotic target. Evolutionary shared processes also regulated the exchange 
of Rab5 and Rab7 proteins in C. elegans efferosomes and mammalian phagosomes, 
suggesting a shared process regulates both phagosome and efferosome maturation51. The 
role of Rab5 and Rab7 in mammalian efferosome maturation remains controversial, as 
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other studies have found differences between C. elegans and mammalian efferosome 
maturation including findings indicating that the Rab5 to Rab7 transition is delayed or 
non-existent in mammalian cells, particularly in dendritic cells where a block in the 
Rab5/7 transition appears to preserve antigens until the DC cell matures64, 65. 
In this thesis, I determined that Rab5 and Rab7 recruitment in efferosome maturation is 
consistent between mammalian macrophages and C. elegans, and that the mammalian 
efferosome maturation process closely paralleled phagosome maturation in the same cell 
type (Figures 7, 8, 9). Upon uptake of phagocytic and efferocytic targets, the engulfed 
particles became Rab5 positive, followed by a rapid exchange of Rab5 for Rab7. 
Although not tested in our experiments, this exchange was most likely driven by the 
Mon1a and Ccz1 proteins, which then act as a Rab7 GEF complex on efferosomes and 
phagosomes52, 59. The presence of Rab7 was associated with fusion to late endosomes and 
lysosomes (Figure 7, 9), confirming that Rab7 was active on efferosomes. Late endosome 
and lysosome fusion to efferosomes delivers V-ATPase into the efferosomal membrane, 
as a result, increasing import of protons and acidifying the efferosome lumen10, 52. These 
results ran contrary to our labs preliminary results from the poorly efferocytic RAW264.7 
cell line, in which efferocytosis did not proceed past the Rab5 stage. The apparent 
conflict between the RAW264.7 cell line and the J774.2 and M0 macrophages maturation 
pathways may be due to the inherent M1 polarized phenotype of the RAW264.7 cells119, 
or alternatively, due to mutations of maturation-regulating protein acquired during the 
immortalization of RAW264.7 cells. A third possibility is that RAW264.7 cells may have 
the same Rab5 blockade as that observed in dendritic cells64, 65, suggesting that we may 
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be able to use RAW264.7 cells as a model of dendritic cell efferocytosis in future studies. 
Indeed, RAW264.7 cells can be differentiated into dendritic-like cells120, suggesting that 
RAW264.7 cells may more closely resemble immature dendritic cells than they resemble 
macrophages. 
While the above results suggest that a shared maturation pathway is used by both 
efferosomes and phagosomes, we assessed the Rab7-dependant fusion of late endosomes 
and lysosomes to the efferosome using a human system comprised of non-polarized (M0) 
primary human macrophages. This was done to confirm our results in endogenous cell 
lines free of any defects caused by the mutations that led to immortalization of the cell 
lines used in the early experiments. Because we cannot transfect primary macrophages, 
we instead assessed the recruitment of the lysosomal protein LAMP-1 to phagosomes 
(Figure 10A) and efferosomes (Figure 10B, C). The recruitment of this protein to both 
efferosomes and phagosomes indicates that both underwent fusion with lysosomes, 
suggesting that full acidification and recruitment of degradative enzymes such as 
cathepsins and hydrolases could occur in both compartments52. However lysosomal cargo 
delivery to efferosomes was not confirmed. As such future experiments should track 
efferosome pH using pH-sensitive fluorescent dextran conjugates121. Should transfection 
of these cells become possible, additional assays of Rab7 function such as monitoring the 
recruitment of fluorescently tagged Rab7 or one of its effector proteins such as RILP, can 
be used to better understand the dynamics of Rab7 activity efferosomes in the human 
system10, 52, 60. Although this thesis determined that efferosomes in human macrophages 
undergo some degree of lysosomal fusion, it is still unclear whether efferosomes are 
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receiving the same complement of degradative proteins as phagosomes. Indeed, it has 
been established that other Rab proteins (e.g. Rab34) can induce the selective delivery of 
molecules to phagolysosomes, suggesting that other Rab proteins may act downstream of 
Rab7 to differentiate efferosome versus phagosomal maturation60. 
4.6 Novel Regulators Differentiate Efferosomal from 
Phagosomal Maturation 
The absence of a major difference between the recruitment of Rab5 and Rab7 to 
phagosomes versus efferosomes, and the apparent normal fusion of late endosomes and 
lysosomes to both compartments, strongly suggests that there are not major differences in 
this portion of the phagosomal versus efferosomal maturation process. However, the 
different immunological outcomes of phagocytosis versus efferocytosis suggest that there 
must be a difference in the way that phagosomal and efferosomal cargos are trafficked19, 
74, 105. Since the maturation process appears to be the same for both types of 
compartments up to the phagolysosome stage, I hypothesized that this difference in cargo 
handling must occur within the phagolysosome itself. To test this hypothesis I 
implemented a mass spectrometry technique to assess the protein content of purified 
phagolysosomes containing apoptotic versus phagocytic targets. This successfully 
identified proteins selectively recruited to either types of targets, allowing us to identify 
putative functional differences between the efferocytosis and phagocytosis maturation 
pathways.  
Mass spectrometry revealed three Rab GTPases that were differentially recruited to 
efferosomes versus phagosomes (Tables 3, 4). Efferosomes recruited Rab17 and Rab45 
88 
 
 
 
whereas phagosomes recruited Rab6b. Although I was unable to assess the role of these 
Rab GTPases in mediating maturation, it seems likely that they play a major role in the 
differential trafficking of efferosome- and phagosome-derived cargos. Previous studies 
found Rab17 on the basolateral membranes and apical tubules of adherent cells where it 
mediates transcytosis85. In addition to its role in transcytosis, Rab17 also interacts with 
recycling endosomes and may contribute to filopodia formations122. Rab17 appears to 
travel toward cell periphery, suggesting it may be carrying degraded apoptotic material 
for “disposal” into the extracellular milieu. Rab45 is not as well characterized and differs 
structurally from most other Rabs. Rab45 has two functionally distinct domains: 1) 
membrane trafficking regulating coiled-coil proteins in C-termini, and 2) an EF-hand 
domain in N-termini with unknown function. Rab45 is present on an uncharacterized 
membrane compartment located in the perinuclear area that is reminiscent of the 
recycling endosome86. Although Rab45’s subcellular localization is unknown, it is clear 
that it is not present on the ER, Golgi or lysosomes, further indicating that the 
efferosomes are recruiting trafficking regulators not typically involved in the processing 
of phagocytic cargos or immunogenic antigen presentation10, 19, 56. Indeed, the combined 
recruitment of Rab17 and Rab45 to efferosomes suggests that efferosomes are interacting 
with compartments not typically involved in antigen loading onto MHC molecules, such 
as the recycling endosome. Taken together, it suggests that efferosomes engages 
recycling endosomes and/or the transcytotic pathway, perhaps to shuttle degraded 
materials out of the phagocyte while avoiding the more acidic lysosomal and multi 
vesicular body compartment where antigen loading onto MHC II typically occurs56, 85. 
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In marked contrast, phagosomes (Table 4) recruited Rab6b along with 
phosphatidylinositol kinase 4 (PIK4) and GTPase of the immunity-associated protein 1 
(GIMD1), all of which are involved in the trafficking of materials from the Golgi to other 
intracellular compartments93, 94, 123. This suggests that the phagosome is in direct 
communication with the Golgi, perhaps for the purpose of delivering unloaded MHC II to 
the phagosome, for loading with phagosome-derived antigen and subsequent antigen 
presentation92. Rab6b GTPases are typically found on the Golgi, ER membranes, and as 
well the ER-Golgi intermediate compartments (ERGIC)93, with the presence of Rab6b on 
phagosomes suggesting that phagosomes directly fused with Golgi-derived vesicles93. 
PI4K generates phosphatidylinositol 4-phosphate, a lipid central to export of vesicles and 
proteins from the Golgi and ER to other vesicles and the cell surface94. GIMD1, anchored 
by a single C-terminal transmembrane helix, is also found on the membrane of the Golgi. 
While GIMD1’s function is unknown, its presence in phagosomes further supports the 
conclusion that there is direct trafficking between the Golgi and phagosomes123. Taken 
together, the presence of these proteins on phagosomes strongly suggests that late 
phagosome maturation occurs through direct interactions with the Golgi, perhaps for the 
delivery of antigen presenting MHC II molecules. 
Other than distinct vesicular trafficking differences between efferosomes and 
phagosomes, different signal transduction proteins were also found to be selectively 
recruited to efferosomes and phagosomes. Phagosomes recruited NOD3 and DOCK10 
(Table 4), both important proteins in mediating inflammation via NF-kB activation, with 
neither protein found on efferosomes124, 125. NOD3 is a member of the Nucleotide-
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binding oligomerization domain-containing proteins family (NOD), of which NOD1 and 
NOD2 are the best characterized and known to activate NF-κB and MAP-Kinases (e.g. 
ERK1/2)99. While NOD1 and NOD2 are known to binding to bacterial peptidoglycan, 
NOD3 is characterized as a critical regulatory component of caspase-1, associated in 
interleukin 1β (IL-1β) production in the inflammasome100, 101. Dedicator of cytokinesis 10 
(DOCK10) was also recovered on phagosomes. DOCK10 has been reported to induce B 
cell activation and IL-4 secretion125. Taken together, the presence of these proteins is 
indicative that phagosomes may be engaging or modulating signaling pathways which 
induce cytokine production and modulate immune cell activation. This is further 
supported by the differential recruitment of other proteins involved in cytokine 
production, discussed in detail below. 
Of great interest on both phagosomes and efferosomes was the differential recruitment of 
MAP-Kinase pathway regulating proteins. Mass spectrometry data identified mitogen-
activated protein kinase (MAPK) interacting serine/threonine kinase 1 (MKNK1) on both 
efferosomes and phagosomes, although the presence of MKNK1 was much more 
probable on phagosomes (Tables 3, 4). MKNK1 acts downstream of MAP-Kinases to 
enhance pro-inflammatory cytokine translation95. Although phagosomes and efferosomes 
both recruited MKNK1, only phagosomes appeared to recruit additional activating 
components of the MAP-Kinase signaling pathway (RalBP1)126, while efferosomes were 
highly enriched in the negative regulator of MAP-Kinase singling PP2A, which inhibits 
MAP-Kinase signaling by inhibiting Raf and MEK127. The recruitment of these two 
distinct sets of MAP-Kinase regulatory proteins suggests different levels of MAP kinase 
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activities are derived from efferocytosis and phagocytosis. MAP kinases are critical 
downstream signaling transducers of pro-inflammatory receptors, often leading to the 
production of several pro-inflammatory cytokines by NF-κB activation128. Upon 
activation of Raf, the downstream signal protein of Rac, MAP kinase kinases (MAP2K) 
are activated to phosphorylate MAP kinases such as p38 MAPK, Erk and Jnk88. p38 
MAPK and Erk subsequently phosphate MKNK1, which enhances cytokine production 
by phosphorylating EIF4E, an elongation factor that promotes cytokine translation129. 
The presence of two positive regulators of MAP-kinase signaling on phagosomes, along 
with the low abundance of PP2A, suggests that the phagosomes likely induced signaling 
through MAP-Kinase cascades, accounting for the pro-inflammatory, NF-κB-dependent 
production of cytokines observed downstream of Fcγ-mediated phagocytosis95. 
Efferosomes recruited an abundant quantity of PP2A, a serine/threonine phosphatase that 
antagonizes MAP-Kinase signaling through dephosphorylation of multiple members of 
the MAP-Kinase signalling cascade127, suggesting that the presence of this phosphatase 
may be why efferocytosis does not induce NF-κB-dependent pro-inflammatory cytokines.  
Another protein of interest is galectin-3, which was found on efferosomes (Table 3), as 
this protein is associated with pro-healing and tissue remodeling activities such as 
fibrogenesis and wound repair13. In addition, recent studies have shown that galectin-3 
also enhances anti-inflammatory responses and promotes the resolution of 
inflammation130. Indeed, galectin-3 has been shown to be important in wound-healing in 
various tissues, with galectin-3 deficiency caused impaired wound healing and promoted 
chronic inflammation (e.g. inflammatory bowel disease)131. Galectin-3 is actively 
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involved in macrophage biology, especially related to polarization into wound healing 
phenotypes, and its anti-inflammatory action directly leads to decreased antigen 
presentation to Th1 cells, although the mechanism of this reduced antigen presentation 
remains unkonwn130, 132, 133. Efferocytosis of apoptotic hepatocytes by hepatic stellate 
cells increased galectin-3 production and secretion, along with TGF-β secretion, further 
linking galectin-3 to anti-inflammatory responses134, 135. Other studies also revealed that 
galectin-3 induced fibrogenesis by myofibroblast proliferation activity in liver tissues, 
potentially by inducing secretion of fibroblast growth factor 2 (FGF2) by macrophages; a 
process known to lead to fibroblasts differentiation into myofibroblasts that form scar 
tissues in wound sites in other tissues13, 136, 137. Taken together, these studies suggest that 
the galectin-3 found on efferosomes may play a role in the anti-inflammatory, pro-wound 
healing outcome of efferocytosis. 
4.7 Summary and Future Aims 
In summary, I have assessed the early and late steps of efferosomes maturation in the 
mammalian system and compared these to the equivalent stages in phagosome 
maturation. I determined that the early maturation stages appear to be identical between 
efferocytosis and phagocytosis, with Rab5 recruited early after internalization and then 
replaced with Rab7 and fusion with late endosomes/lysosomes at later time points. This 
indicates that efferosomes should undergo acidification with the subsequent activation in 
proteases and other degradative enzymes to process apoptotic cells51, although I was not 
able to test this directly in this thesis.  Mass spectrometry analysis of efferosomes and 
phagosomes at the phagolysosome stage of maturation identified several interesting 
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differences between phagosomes and lysosomes, potentially identifying the mechanism 
by which efferocytic cargos induce the opposite immune response as do phagocytic 
cargos. For example, different vesicular trafficking mediated by Rab17 and Rab45 may 
keep efferosome-derived antigens from the antigen-loading compartment in macrophages 
by directing these antigens to recycling endosomes. In contrast, phagosomes had 
abundant MHC II and directly interacted with the Golgi trafficking regulators Rab6b, 
PIK4 and GIMD1, indicating the phagosome was receiving MHC II directly from the 
Golgi network, perhaps for efficient loading of pathogen-derived antigens onto MHC II. 
Lastly, MAP kinase regulators accumulated on efferosomes and phagosomes in a pattern 
suggesting that MAP Kinase activity and NF-κB activation would occur on phagosomes 
but be impaired on efferosomes. These findings will lead to future studies which will 
seek to validate the mass spectrometry observations, and to characterize the roles of these 
proteins in mediating the differential immune responses following efferocytosis and 
phagocytosis. 
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